levodopa has been researched along with Dystonia in 412 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 67 (16.26) | 18.7374 |
| 1990's | 154 (37.38) | 18.2507 |
| 2000's | 111 (26.94) | 29.6817 |
| 2010's | 60 (14.56) | 24.3611 |
| 2020's | 20 (4.85) | 2.80 |
| Authors | Studies |
|---|---|
| Balint, B; Bhatia, KP; Fung, VSC; Morales-Briceno, H | 1 |
| Eskow Jaunarajs, KL; Hess, EJ; Scarduzio, M; Standaert, DG | 1 |
| Kajiyama, Y; Mochizuki, H | 1 |
| Cerquera-Cleves, C; Dulski, J; Koziorowski, D; Kwiatek-Majkusiak, J; Milanowski, L; Pentela-Nowicka, J; Ross, OA; Sławek, J; Wszolek, ZK | 1 |
| Ganaraja, VH; Kodapala, S; Krishnaveni, V; Mala, K | 1 |
| Belvisi, D; Berardelli, A; Bologna, M; Conte, A; Guerra, A; Kamble, N; Pal, PK; Valls-Solè, J | 1 |
| Biskup, S; Fietzek, UM; Mueller, C; Schneider, SA; Schroeder, AS | 1 |
| Cherian, A; K P, D; Krishnan, S; Vijayaraghavan, A | 1 |
| Bernhard, D; Bonno, SQ; Briscione, MA; Campbell, SA; Donsante, Y; Downs, AM; Fan, X; Gutman, D; Hess, EJ; Ingram, J; Jinnah, HA; Roman, KM; Sardar, TA; Sutcliffe, DJ | 1 |
| Cai, ZJ; Chang, PP; Li, YZ; Wei, LK; Yang, L; Zhang, GY; Zhang, XL; Zhang, YP; Zhu, DN | 1 |
| de Ricchezza, LL; Soares, VP; Vasconcellos, LF | 1 |
| Ikezawa, J; Shimazaki, R; Sugaya, K; Takahashi, K; Tobisawa, S | 1 |
| Cenci, MA; Espa, E; Grigoriou, S; Jakobsson, A; Odin, P; Timpka, J; von Grothusen, G | 1 |
| Bhidayasiri, R; Panyakaew, P; Thongchuam, Y | 1 |
| An, J; Chan, P; Han, C; Jiao, L; Mao, W | 1 |
| Frucht, S; Han, SC; Katus, L | 1 |
| Mittal, SO | 1 |
| Cherian, A; Divya, KP; Paramasivan, NK | 1 |
| Bohn, E; Falck-Ytter, Y; Fehlings, D; Goren, K; Switzer, L | 1 |
| Alt, K; Berner, D; Krämer, J; Meinhardt, T; Wenzel, M; Winkelmann, J; Winter, B; Zech, M | 1 |
| Lin, JP; Maas, RPPWM; van de Warrenburg, BPC; Wassenberg, T; Willemsen, MAAP | 1 |
| Augustine, EF; Gilbert, DL | 1 |
| Augustine, GJ; Cho, KH; Cho, SH; Chung, JH; Jeong, M; Jeong, Y; Jo, S; Kim, D; Kim, J; Kim, Y; Nakajima, R; Paik, SB; Park, AH; Park, H; Shim, I; Shin, A; Yang, S | 1 |
| Cestari, DM; Eichler, FS; Hunt, AL; Rapalino, O; Swoboda, KJ | 1 |
| Coleman, M | 1 |
| Maas, RPPWM; van de Warrenburg, BPC; Willemsen, MAAP | 1 |
| Buhmann, C; Hauptmann, B; Modreanu, R; Özdemir, G | 1 |
| Balint, B; Bhatia, KP; Jankovic, J; Mencacci, NE; Pisani, A; Rothwell, J; Valente, EM; Vidailhet, M | 1 |
| Kuo, MC; Lin, CH; Lin, HI | 1 |
| Bhatia, KP; Lang, AE; Shetty, AS | 1 |
| Jinnah, HA | 1 |
| Aoki, M; Hasegawa, T; Kaneko, K; Kikuchi, A; Takeda, A; Tano, O | 1 |
| Barone, P; Bovi, T; Censi, D; Fasano, A; Juergenson, I; Montemezzi, S; Squintani, G; Tinazzi, M; Vattemi, G | 1 |
| Amboni, M; Annesi, G; Barbosa, ER; Barone, P; Bonifati, V; Breedveld, GJ; Chien, HF; Erro, R; Fang, M; Graafland, J; Olgiati, S; Oostra, BA; Pappatà, S; Picillo, M; Quadri, M; Quarantelli, M; Quattrone, A; Wang, J; Wu, B; Xu, F | 1 |
| Heidenreich, WF | 1 |
| Goodchild, RE; Grundmann, K; Pisani, A | 1 |
| Costello, D; Lynch, T; McCarthy, A; Mulroy, E; Ross, OA | 1 |
| Cenci, MA | 1 |
| Merello, M; Rossi, M | 1 |
| LeDoux, MS; Pfeiffer, RF | 1 |
| Fan, X; Harrast, P; Heinzer, AK; Hess, EJ; Jinnah, HA; Pare, JF; Raike, RS; Rose, SJ; Smith, Y; Thompson, VB; Weinshenker, D; Yu, XY | 1 |
| Abbruzzese, G; Barone, P; Bentivoglio, A; Canesi, M; Cannas, A; Ceravolo, R; Cossu, G; Dallocchio, C; Defazio, G; Fabbrini, G; Fasano, A; Geroin, C; Marconi, R; Mirandola, R; Modugno, N; Morgante, F; Pacchetti, C; Pisani, A; Rossi, S; Tamma, F; Thomas, A; Tinazzi, M; Vitale, C; Volontè, MA; Zappia, M | 1 |
| Kaminska, M; Lin, JP; Lumsden, DE; Tomlin, S | 1 |
| Friedman, JR | 1 |
| Espay, AJ; Fasano, A; Lovera, LC; Rodriguez-Porcel, F; Urrea-Mendoza, E | 1 |
| Kanaya, Y; Kono, R; Kuriyama, M; Shiga, Y; Shimoe, Y; Takeshima, S | 1 |
| Mottet, L | 1 |
| Abu-Arafeh, I; Combe, L | 1 |
| Adachi, H; Takei, T; Toyota, T; Uozumi, T; Yasuda, C; Yuhi, T | 1 |
| Hallett, M; Li, J; Li, X; Li, Y; Zhang, Y; Zhuang, P | 1 |
| Brotchie, JM; Groh, J; Higuchi, T; Ip, CW; Isaias, IU; Klein, D; Knorr, S; Koprich, JB; Kusche-Tekin, BB; O'Leary, A; Reif, A; Toyka, KV; Volkmann, J | 1 |
| Maiola, R; Micheli, F; Ramirez Gómez, CC | 1 |
| Gee, L; Pilitsis, JG; Ramirez-Zamora, A; Shin, DS; Youn, Y | 1 |
| Park, D | 1 |
| Chen, WJ; Lin, Y; Murong, SX; Wang, N; Wu, ZY; Xie, H; Zhao, GX | 1 |
| Artuch, R; Briones, P; Carrilho, I; Duarte, S; Garcia-Cazorla, A; Garesse, R; Montoya, J; Nascimento, A; Ormazabal, A; Pineda, M; Sala-Castellvi, P; Serrano, M | 1 |
| Hasegawa, K; Ikeda, T; Kanmura, K; Kodama, Y; Nunoi, H; Sawada, K | 1 |
| Hagenah, J; Klein, C; Schmidt, A; Schneider, SA | 1 |
| Kieburtz, K | 1 |
| Albanese, A; Del Sorbo, F | 1 |
| Aasly, JO; Beiske, AG; Bekkelund, SI; Dietrichs, E; Larsen, JP; Tysnes, OB; Vilming, ST | 1 |
| Bayliss, M; Harper, A; Nisbet, A; Saha, R; Scutt, A | 1 |
| Hartsilver, EL; Sinha, A | 1 |
| Aguiar, PM; Barsottini, OG; Borges, V; Felício, AC; Ferraz, HB; Godeiro-Junior, C; Silva, SM | 1 |
| Asmus, F; Doherty, E; Gasser, T; King, MD; Langseth, A; Lynch, T; Munz, M; Nestor, T | 1 |
| Blau, N; Jakobs, C; Jansen, EE; Kusmierska, K; Malunowicz, E; Meilei, D; Pronicka, E; Rokicki, D; Sykut-Cegielska, J; Szymanska, K; Thony, B; Tryfon, J | 1 |
| Liu, L; Luciano, MS; Ozelius, L; Raymond, D; Saunders-Pullman, R; Sims, K | 1 |
| Ben-Shlomo, Y; Morris, HR; Wickremaratchi, MM | 1 |
| Durić, G; Dzoljić, E; Kostić, V; Svetel, M | 1 |
| Cannas, A; Floris, G; Marrosu, F; Marrosu, MG; Piga, M; Serra, A; Solla, P; Tacconi, P | 1 |
| Bhatia, KP; Davis, MB; Edwards, MJ; Gerhard, A; Hanna, MG; Mir, P; Polke, JM; Schwingenschuh, P; Sweeney, MG; Trender-Gerhard, I; Wood, NW | 1 |
| Gross-Paju, K; Segawa, M; Talvik, I; Talvik, T; Veri, K | 1 |
| Baba, Y; Matsubara, S; Suzuki, M; Suzuki, T; Tanaka, H; Watanabe, T | 1 |
| Blond, S; Defebvre, L; Delval, A; Destée, A; Devos, D; Dujardin, K; Kreisler, A; Krystkowiak, P; Salleron, J; Simonin, C; Tir, M | 1 |
| Cardoso, E; Lucena, R; Melo, A | 1 |
| Bardien, S; Carr, J; du Plessis, M; Human, H; Keyser, R; Lombard, D | 1 |
| Soghomonian, JJ; Yamamoto, N | 1 |
| Araki, S; Hayashi, M; Kohyama, J; Miyata, R; Sasaki, T; Shimohira, M | 1 |
| Fang, DF; Guo, XY; Liu, X; Ma, MY; Shang, HF; Yang, Y; Zhang, SS | 1 |
| Lee, MS; Lyoo, CH | 1 |
| Dale, RC; Earl, J; Fung, VS; Grattan-Smith, P; Houlden, H; Melchers, A | 1 |
| Cao, L; Chen, SD; Ding, JQ; He, SB; Tang, HD; Tang, WG; Wang, XJ; Xiao, Q; Zhang, T; Zheng, L | 1 |
| Mink, JW; Zinner, SH | 1 |
| McKee, PJ; Wong, SH | 1 |
| Aono, K; Hanayama, K; Hyodo, M; Kasahara, T; Kodama, M; Koyama, Y; Masakado, Y; Sugaya, M | 1 |
| Bakay, RA; Deogaonkar, M; Lieu, CA; Subramanian, T | 1 |
| Hamann, M; Lange, N; Richter, A; Shashidharan, P | 1 |
| Davis, MB; Haworth, A; Heales, SJ; Lees, AJ; Ling, H; Polke, JM; Sandford, CA; Sweeney, MG; Wood, NW | 1 |
| Gomez Heredia, MJ; Pérez Errazquin, F | 1 |
| Antonini, A; Biundo, R; D'Avella, D; Ferla, S; Landi, A; Padoan, A; Pilleri, M | 1 |
| Biswas, A; Das, SK; Misra, AK; Naiya, T; Ray, J; Ray, K | 1 |
| Bassi, MS; Galati, S; Imbriani, P; Marzetti, F; Olivola, E; Pastore, FS; Petrucci, S; Pierantozzi, M; Stefani, A; Valente, EM | 1 |
| Gerlach, M; Halley, P; Riederer, P; van den Buuse, M | 1 |
| Birthi, P; McDowell, S; Perry, D; Salles, S | 1 |
| Benrhouma, H; Gouider-Khouja, N; Klaa, H; Kraoua, I; Rouissi, A; Turki, I | 1 |
| Reichel, G; Stenner, A | 1 |
| Derkinderen, P; Lebouvier, T; Pouclet, H | 1 |
| Camargos, S; Cardoso, F; Lees, AJ; Singleton, A | 1 |
| Corsmit, E; Cras, P; Crosiers, D; De Deyn, PP; Debaene, L; Del-Favero, J; Elinck, E; Engelborghs, S; Goossens, D; Mattheijssens, M; Meeus, B; Nuytemans, K; Peeters, K; Pickut, B; Sleegers, K; Theuns, J; Van Broeckhoven, C | 1 |
| Blau, N; Hoffmann, GF; Kühn, AA; Opladen, T | 1 |
| Furukawa, Y; Haycock, JW; Kapatos, G; Kish, SJ; Nygaard, TG; Wong, H; Worsley, J | 1 |
| Kachi, T | 1 |
| Ichinose, H; Ihara, M; Ikeda, A; Kawamoto, Y; Kohara, N; Nishida, T; Saiki, H; Shibasaki, H; Takagi, S; Takao, S; Urano, F | 1 |
| Katzenschlager, R; Lees, AJ | 1 |
| Antonozzi, I; Artiola, C; Cardona, F; Carducci, C; Leuzzi, V | 1 |
| Bioulac, B; Fernagut, PO; Ghorayeb, I; Stefanova, N; Tison, F; Wenning, GK | 1 |
| Aniello, MS; De Mari, M; Defazio, G; Lamberti, P; Zenzola, A | 1 |
| Angelini, L; Blau, N; Fernandez Alvarez, E; Garavaglia, B; Invernizzi, F; Nardocci, N; Pannacci, M; Sesta, M; Zorzi, G | 1 |
| Bandmann, O; Deuschl, G; Goertz, M; Hefter, H; Hoffmann, G; Jost, W; Müller, U; Oertel, W; Zöfel, P; Zschocke, J | 1 |
| Chan, LL; Tan, EK; Wong, MC | 1 |
| Dupont, E; Guldberg, P; Güttler, F; Krag-Olsen, B; Romstad, A; Østergaard, K | 1 |
| Bhatia, KP; Critchley, P; Graham, E; Khan, NL; Lees, AJ; Quinn, N; Schrag, AE; Wood, NW | 1 |
| Law, HY; Ng, I; Tan, EK; Wilder-Smith, E; Wong, MC; Zhao, Y | 1 |
| Assmann, B; Bräutigam, C; de Klerk, JB; Dionisi-Vici, C; Häussler, M; Hoffmann, GF; Naumann, M; Steenbergen-Spanjers, GC; Strassburg, HM; Wevers, RA | 1 |
| Li, Y; Tang, X | 1 |
| Hironishi, M; Kondo, T; Miwa, H; Nakanishi, I | 1 |
| Furukawa, Y | 1 |
| Nishiyama, N; Nomura, Y; Segawa, M; Yokochi, M; Yukishita, S | 1 |
| Kishore, D; Misra, S; Singh, NN; Verma, R | 1 |
| Hwang, WJ; Ting, G; Wey, SP; Yao, WJ | 1 |
| Nutt, JG | 1 |
| Fahn, S; Furukawa, Y; Kish, SJ | 1 |
| Helenius, H; Iivanainen, M; Metsähonkala, L; Någren, K; Pääkkönen, L; Rinne, JO; Vainionpää, L | 1 |
| Calne, DB; de la Fuente-Fernández, R; Mak, E; Schulzer, M; Stoessl, AJ | 1 |
| Cokar, O; Dervent, A; Saltik, S; Uludüz, D; Uslu, T | 1 |
| Klein, C | 1 |
| Banach, M; Bogucki, A; Budrewicz, S; Friedman, A; Sławek, J | 1 |
| Arai, H; Fujihara, K; Ichinose, H; Itoyama, Y; Kikuchi, A; Kimpara, T; Nagai, M; Okamura, N; Shiga, Y; Takeda, A; Tanji, H; Urano, F | 1 |
| Fan, SW; Hwa, KY; Hwu, WL; Lee, YM; Lu, MY | 1 |
| Bird, TD; Bower, J; Calne, DB; de la Fuente-Fernandez, R; Farrer, M; Furtado, S; Gwinn-Hardy, K; Hanson, M; Hardy, J; Klimek, ML; Lockhart, PJ; Nutt, JG; Payami, H; Singleton, A; Singleton, AA; Stoessl, AJ; Suchowersky, O; Tsuboi, Y; Utti, RJ; Wszolek, ZK | 1 |
| Lo, TC; Thanvi, BR | 1 |
| Annesi, G; De Angelis, MV; Di Fulvio, P; Filla, A; Gambi, D; Ragno, M; Stuppia, L; Uncini, A | 1 |
| Mizusawa, H; Nishina, K | 1 |
| Jan, MM | 1 |
| Blau, N; Jung, HH; Schiller, A; Steenbergen, GC; Wevers, RA | 1 |
| Chu, NS | 1 |
| Davis, V; Lindsey, N; Marks, WJ; Ostrem, JL; Rau, GM; Simmons, D; Starr, PA; Turner, RS | 1 |
| Asanuma, K; Bressman, SB; Carbon-Correll, M; Edwards, C; Eidelberg, D; Huang, C; Ma, Y; Moeller, JR; Raymond, D | 1 |
| Angelini, L; Broggi, G; Caldiroli, D; Chiapparini, L; Franzini, A; Maccagnano, E; Marras, C; Nardocci, N; Zorzi, G | 1 |
| Lang, AE | 3 |
| Blau, N; de Villemeur, TB; Doummar, D; Moller, LB; Roubergue, A; Roze, E; Vidailhet, M | 1 |
| Blau, N; Friberg, L; Hertz, JM; Hjermind, LE; Johannsen, LG; Lucking, CB; Nielsen, JE; Regeur, L; Sørensen, SA; Wevers, RA | 1 |
| Ludolph, A; Odin, P; Oehlwein, C; Polzer, U; Renner, R; Schüler, P; Shing, M; Storch, A; Werner, G | 1 |
| Mink, JW | 1 |
| Atsumi, M; Hattori, N; Li, Y; Sato, K; Tomiyama, H | 1 |
| Haginoya, K; Higano, S; Iinuma, K; Ishitobi, M; Kitamura, T; Nara, T; Onuma, A; Togashi, N; Wakusawa, K; Yokoyama, H | 1 |
| Benabid, AL; Chabardes, S; Chevrier, E; Fraix, V; Krack, P; Pollak, P | 1 |
| Van Gerpen, JA | 1 |
| Becker, B; Hagenah, JM; Hedrich, K; Klein, C; Pramstaller, PP; Seidel, G | 1 |
| Defazio, G; Lamberti, P; Livrea, P; Martino, D; Zoccolella, S | 1 |
| Bain, PG; Hensman, DJ | 1 |
| Grant, PE; Sims, KB; Venna, N | 1 |
| Li, ZW; Lin, MT; Murong, SX; Wang, N; Wu, ZY; Xie, H | 1 |
| Mercimek-Mahmutoglu, S; Stockler-Ipsiroglu, S | 1 |
| Ceballos-Baumann, A | 1 |
| Lennox, G; Misbahuddin, A; Placzek, M; Taanman, JW; Warner, TT | 1 |
| Neville, B | 1 |
| Fujioka, H; Kosakai, A; Nagata, E; Segawa, M; Shintaku, H; Suzuki, N; Tanaka, K | 1 |
| Meinck, HM; Regula, JU; Thoden, U | 1 |
| Clement, F; Coubes, P; Defebvre, L; Destee, A; Devos, D; Moreau, C | 1 |
| Baker, M; Burkhard, PR; Cannon, A; Cobb, SA; Coon, KD; Farrer, MJ; Gass, J; Ghika, J; Hauf, M; Hutton, M; Kachergus, JM; Kapatos, G; Melquist, S; Schorderet, DF; Solida, A; Stephan, DA; Vingerhoets, FJ; Wider, C; Wszolek, ZK | 1 |
| Ho, B; Morgan, JC; Prakash, R; Sethi, KD | 1 |
| Brown, P; Eusebio, A | 1 |
| Camargos, ST; Cardoso, F; Gianetti, JG; Hardy, J; Lees, A; Momeni, P; Singleton, A | 1 |
| Segawa, M | 4 |
| Deonna, T; Stephenson, J | 1 |
| Amaral, VG; Carducci, C; Giovanniello, T; Lorenzoni, PJ; Scola, RH; Teive, HA; Werneck, LC | 1 |
| Horstink, MW | 1 |
| Lees, AJ; Stern, GM | 1 |
| Hallett, M | 1 |
| Lee, MC | 1 |
| Gooskens, RH; van Nieuwenhuizen, O; Westenberg, HG; Willemse, J | 1 |
| Albizzati, MG; Bassi, S; Frattola, L; Spano, PF; Trabucchi, M | 1 |
| Arnal García, C; Bermejo Pareja, F; Calandre Hoenigsfeld, L; Molina Arjona, JA | 1 |
| Koga, I; Nishikawa, T; Tanaka, M; Tsuda, A; Uchida, Y | 1 |
| Chan-Lui, WY; Low, LC | 1 |
| Igata, A; Kumamoto, I; Nomoto, M; Osame, M; Yoshidome, H | 1 |
| Rondot, P; Ziegler, M | 1 |
| Ortiz, A | 1 |
| Nausieda, PA; Weiner, WJ | 1 |
| Gordon, N | 2 |
| Korein, J | 1 |
| Klawans, HL; Nausieda, PA; Weiner, WJ | 1 |
| McKenna, P; Pratt, RT; Stern, GM; Ward, C | 1 |
| Chkili, T; el Alaoui-Faris, M; Nadifi, M; Ouahabi, H | 1 |
| Diament, A; Gherpelli, JL; Nagae, LM | 1 |
| Davis, JS; Heckmatt, JZ; Patel, K; Roskrow, T | 1 |
| Iivanainen, M; Kaakkola, S | 2 |
| Hirano, M; Imai, T; Ito, H; Nagai, Y; Tamaru, Y; Ueno, S | 1 |
| Ishikawa, A; Miyatake, T | 1 |
| Nygaard, TG | 2 |
| Borgohain, R; Mohandas, S; Radhakrishna, H; Rao, VC; Singh, AK | 1 |
| Hsu, KY; Hsu, RW; Kuo, KN | 1 |
| Fujita, K; Ichinose, H; Nagatsu, T; Ohye, T; Yokochi, M | 1 |
| Albani, G; Alfonsi, E; Godi, L; Martignoni, E; Nappi, G; Pacchetti, C | 1 |
| Crossman, AR; Page, RD; Sambrook, MA | 1 |
| Endo, K; Nomura, Y; Nygaard, TG; Segawa, M; Tanaka, H; Tsuji, S; Weeks, DE | 1 |
| Bertini, E; Di Capua, M | 1 |
| Cho, K; Ito, J; Tanaka, H; Tasaki, T | 1 |
| Calne, DB; Doudet, D; Hewitt, KA; Nugent, R; Olanow, W; Pate, BD; Perl, DP; Shinotoh, H; Snow, BJ | 1 |
| Furukawa, Y; Mizuno, Y; Narabayashi, H; Nishi, K | 1 |
| Chien, YY; Hsu, KY; Hsu, WW; Wang, KC | 1 |
| Bour, LJ; Hilgevoord, AA; Koelman, JH; Ongerboer de Visser, BW; Speelman, JD | 1 |
| Ahuja, GK; Behari, M; Padma, MV | 1 |
| Endo, K; Hori, T; Ichinose, H; Nomura, Y; Ohye, T; Segawa, M; Seki, N; Takahashi, E; Tanaka, H; Tsuji, S | 1 |
| Chutorian, AM; Levine, RA; Naini, AB; Nygaard, TG; Waran, SP | 1 |
| Frenkel, C; Jalil, P; Miranda, MC | 1 |
| Furukawa, Y; Imai, H | 1 |
| Chang, LG; Gibb, WR; Hornykiewicz, O; Kish, S; Rajput, AH; Shannak, KS; Zhong, XH | 1 |
| Crabb, L | 1 |
| Kuzuhara, S; Naito, Y; Narita, Y; Sasaki, R; Taniguchi, A | 1 |
| Marsden, CD; Sawle, GV | 1 |
| Fahn, S; Lew, MF; Moskowitz, CB; Shindo, M; Waters, CH; Wilhelmsen, KC | 1 |
| Ishikawa, A | 1 |
| Lal, TR; Ong, LC; Tang, SF | 1 |
| Calne, DB; Galloway, MP; Levine, RA; Nygaard, TG; Snow, BJ; Takahashi, H | 1 |
| Agid, Y; Bonnet, AM; Dubois, B; Lefebvre-Caparros, D; Marconi, R; Vidailhet, M | 1 |
| Araújo, Ade Q; Miranda, SB | 1 |
| Fletcher, NA; Harwood, G; Hierons, R; Marsden, CD | 1 |
| Lang, AE; Mark, MH; Sage, JI; Zimmerman, TR | 1 |
| Calne, DB; Nygaard, TG; Snow, BJ; Takahashi, H | 2 |
| Kodama, H; Okabe, I; Shimoizumi, H; Yanagisawa, M | 1 |
| Mimori, Y; Nakamura, S | 1 |
| Akiguchi, I; Nakamura, S | 1 |
| Maruta, K; Okamoto, S; Takegami, T | 1 |
| Fletcher, NA; Marsden, CD; Scadding, JW; Thompson, PD | 1 |
| Bhatia, K; Brooks, DJ; Burn, DJ; Marsden, CD; Sawle, GV; Turjanski, N | 1 |
| Bravi, D; Chase, TN; Davis, TL; Mouradian, MM; Roberts, JW | 1 |
| Hirato, M; Horikoshi, S; Kawashima, Y; Ohye, C; Satake, K; Shibazaki, T | 1 |
| Caraceni, T; Carella, F; Giovannini, P; Girotti, F; Testa, D | 1 |
| Furukawa, Y; Kondo, T; Mizuno, Y; Narabayashi, H; Nishi, K | 1 |
| Nomura, Y; Segawa, M | 1 |
| Bhatt, MH; Calne, DB; Nakamura, K; Nomoto, M; Okada, A; Osame, M; Snow, BJ | 1 |
| Fornadi, F; Pantelatos, A | 1 |
| Cornelius, L; Factor, SA; Ingenito, A; Sanchez-Ramos, JR; Sheldon, C; Singer, C; Weiner, WJ | 1 |
| Caldarola, M; de Mari, M; Iliceto, G; Lamberti, P; Serlenga, L | 1 |
| Duchek, M; Ekberg, R; Fehling, C; Johansson, F; Johnels, B; Lindvall, B; Nordin, G; Olsson, JE; Sidén, A; Steg, G | 1 |
| Bartholomé, K; Flatmark, T; Knappskog, PM; Lüdecke, B; Mallet, J | 1 |
| Easaw, PE; Tan, KK | 1 |
| Furukawa, Y; Mizuno, Y; Narabayashi, H | 1 |
| Chase, TN; Papa, SM | 1 |
| Chen, RS; Huang, CC; Lu, CS | 1 |
| Ho, HH; Kwan, SY; Shan, DE; Su, MS | 1 |
| Bandmann, O; Harding, AE; Marsden, CD; Nygaard, TG; Surtees, R; Wood, NW | 1 |
| Phanthumchinda, K; Vichichanyakul, M; Yodnophaklao, P | 1 |
| Miwa, H; Mizuno, Y | 1 |
| Akiguchi, I; Fukuyama, H; Hanakawa, T; Kato, M; Kimura, J; Shibasaki, H | 1 |
| Hirano, M; Imai, T; Ito, H; Matsumoto, S; Tamaru, Y; Ueno, S | 1 |
| Deonna, T; Ghika, J; Roulet, E; Zesiger, P | 1 |
| Fukuda, T; Iwata, S; Kaseda, S; Nomoto, M; Osame, M | 1 |
| Hagay, Z; Lurie, S; Priscu, V | 1 |
| Hanihara, T; Inoue, K; Iwabuchi, K; Kawanishi, C; Kosaka, K; Miyakawa, T; Onishi, H; Osaka, H; Owada, M; Sugiyama, N; Yamada, Y | 1 |
| Becker, G; Brücke, T; Lange, K; Naumann, M; Pirker, W; Reiners, K | 1 |
| Bolton, CF; Kishore, A; Rajput, A; Rajput, AH; Snow, B | 1 |
| Hirano, M; Imaiso, Y; Ueno, S | 1 |
| Jiménez-Jiménez, FJ; Molina, JA | 1 |
| de la Fuente-Fernández, R | 2 |
| Jeon, BS | 1 |
| Bartholomé, K; Lüdecke, B | 1 |
| Birdi, S; Fenton, Me; Macaulay, R; Rajput, AH | 1 |
| Bosch, DA; de Bie, RM; Schuurman, PR; Speelman, JD | 1 |
| Hirano, M; Imaiso, Y; Kaneda, N; Kira, J; Taniwaki, T; Ueno, S; Yamada, T; Yoshimura, T | 1 |
| Hagay, Z; Lurie, S; Priscu, V; Rabinerson, D; Savir, I | 1 |
| Chase, TN; Lenz, FA; van den Munckhof, P | 1 |
| Nygaard, TG; Wooten, GF | 1 |
| Bird, TD; Furukawa, Y; Guttman, M; Hornykiewicz, O; Hunter, A; Kish, SJ; Lang, AE; Morris, LW; Sadeh, M; Shimadzu, M; St George-Hyslop, PH; Tagawa, T; Trugman, JM | 1 |
| Bezin, L; Levine, RA; Neville, JD; Nygaard, TG; Shen, H | 1 |
| Calne, DB; de la Fuente-Fernandez, R; Kishore, A; Mak, E; Naini, AB; Nygaard, TG; Ruth, TJ; Schulzer, M; Snow, BJ; Stoessl, AJ | 1 |
| Benecke, R; Deuschl, G; Korinthenberg, R; Martinius, J; Müller, U; Steinberger, D; Weber, Y | 1 |
| Illarioshkin, SN; Ivanova-Smolenskaya, IA; Limborska, SA; Markova, ED; Miklina, NI; Popova, SN; Slominsky, PA; Tsuji, S | 1 |
| Chang, YS; Jeon, BS; Jeong, JM; Kim, JM; Kim, KM; Lee, MC; Lee, SB; Park, SS; Song, HC; Yoon, KY | 1 |
| Heberlein, I; Müller, U; Nitschke, M; Otto, V; Steinberger, D; Vieregge, P | 1 |
| Bebin, EM; Fryburg, JS; Furukawa, Y; Hyland, K; Jacobson, RD; Kish, SJ; Shimadzu, M; Trugman, JM; Wilson, WG | 1 |
| Arias, M; Lema, C; Requena, I | 1 |
| Bennett, JP; Currie, LJ; Harrison, MB; Trugman, JM; Wooten, GF | 1 |
| de Rijk-van Andel, JF; Hyland, K; Janssen, RJ; Luiten, B; Smeitink, JA; Steenbergen-Spanjers, GC; van den Heuvel, LP; Wevers, RA | 1 |
| Chouinard, G; Looper, KJ | 1 |
| Bräutigam, C; de Rijk-van Andel, JF; Gabreëls, FJ; Hoffmann, GF; Jansen, RJ; Smeitink, JA; Wevers, RA | 1 |
| Hachimori, K; Hagiwara, H; Nishiyama, N; Nomura, Y; Segawa, M; Tanaka, R; Tanaka, T; Uetake, K; Yukishita, S | 1 |
| Furukawa, Y; Hornykiewicz, O; Kish, SJ; Shimadzu, M | 1 |
| Anastasiadis, PZ; Bezin, L; Levine, RA; Nygaard, TG | 1 |
| Arnold, LA; Hyland, K; Trugman, JM | 1 |
| Bencsics, C; Kang, UJ; Lew, R; Wachtel, S | 1 |
| Jeon, BS; Jeong, JM; Lee, MC; Park, SS | 1 |
| Onofrj, M; Paci, C; Thomas, A | 1 |
| Dewey, RB; Kishore, A; Muenter, MD; Snow, BJ | 1 |
| Kuzuhara, S; Naito, Y; Sasaki, R | 1 |
| Bandmann, O; Dobbie, M; McCarthy, GT; Robinson, R; Surtees, R; Wood, NW | 1 |
| Holsteen, V; Rasmussen, MB | 1 |
| Aderbauer, J; Bock, E; Eilles, C; Fiedler, A; Marienhagen, J; Segerer, H | 1 |
| Chaudhary, N; Mani, J; Mulye, R; Rawat, S; Shah, P | 1 |
| Hagell, P; Widner, H | 1 |
| Güttler, F; Romstad, A | 1 |
| Benabid, AL; Benazzouz, A; Deuschl, G; Krack, P; Limousin, P; Pollak, P | 1 |
| Behari, M; Denny, AP | 1 |
| Moerlein, SM; Perlmutter, JS | 1 |
| Illarioshkin, SN; Ivanova-Smolenskaya, IA; Limborska, SA; Markova, ED; Miklina, NI; Popova, SN; Slominsky, PA | 1 |
| Furukawa, Y; Kish, SJ | 1 |
| Bhatia, KP; Marsden, CD; Mathen, D | 1 |
| Chaná, P; Miranda, M | 1 |
| Ichinose, H; Inagaki, H; Nagatsu, T; Ohye, T; Suzuki, T | 1 |
| Benecke, R; Deuschl, G; Müller, U; Steinberger, D; Weber, Y | 1 |
| Imahori, Y; Kawano, H; Misawa, A; Sawada, T; Takeuchi, Y | 1 |
| Furukawa, Y; Guttman, M; Hyland, K; Kish, SJ; Lang, AE; Rouleau, GA; Shimadzu, M; Sparagana, SP; Trugman, JM; Wyatt, P | 1 |
| Mulas, F | 1 |
| Andringa, G; Cools, AR; Drukarch, B; Lubbers, L; Stoof, JC | 1 |
| Finken, MJ; Ramaker, C; Van de Beek, WJ; van Hilten, JJ | 1 |
| Abada, M; Agid, Y; Bartholomé, B; Bonnet, AM; Brice, A; Durif, F; Dürr, A; Echenne, B; Gil, R; Goas, JY; Jedynak, P; Lacomblez, L; Lagueny, A; Lücking, CB; Motte, J; Tassin, J; Vidailhet, M | 1 |
| Bressman, SB; Ford, B; Greene, PE; Hyland, K | 1 |
| Furukawa, Y; Kish, SJ; Lang, AE | 1 |
| Kimber, TE; Thompson, PD | 1 |
| Fung, VS; Hely, MA; Morris, JG | 1 |
| Jankovic, J; Vanek, Z | 1 |
| García de Yébenes, J; Godoy, M; Hoenicka, J; Ochoa, JJ; Vidal, L | 1 |
| Hong, KM; Kim, YS; Paik, MK | 1 |
| Nutt, JG; Nygaard, TG | 1 |
| Misbahuddin, A; Warner, TT | 1 |
| Calne, DB; de la Fuente-Fernández, R; Hwang, WJ; Tsui, JK | 1 |
| Bartholomé, B; Bartholomé, K; Blau, N; Bonafé, L; Skrygan, M | 1 |
| Rajput, AH | 1 |
| Jankovic, J; Tintner, R | 1 |
| Becker, G; Berg, D; Naumann, M; Reiners, K | 1 |
| Ohye, C | 1 |
| Boesch, SM; Poewe, W; Ransmayr, G; Wenning, GK | 1 |
| Burkhard, PR; Ghika, J; Grötzsch, H; Landis, T; Pizzolato, GP; Schorderet, D; Vingerhoets, FJ | 1 |
| Calne, DB; Eisler, T | 1 |
| Godwin-Austen, RB | 1 |
| Melamed, E | 1 |
| Basso, PF; Gasco, P; Montanini, R | 1 |
| Adlmici, G; Callea, L; Di Monda, V; Fazzari, G | 1 |
| Aicardi, J; Goutières, F; Rondot, P; Ziegler, M | 1 |
| Fredow, G; Löscher, W | 1 |
| Calne, DB; Fahn, S; Heiman, GA; Nygaard, TG; Snow, BJ; Takahashi, H | 1 |
| Kaiser, R; Ziegler, G | 1 |
| Court, J; Godoy, J; Valenzuela, R | 1 |
| Couillault, G; Dumas, R; Giroud, M; Gras, P; Nivelon, JL; Septien, L | 1 |
| Markham, CH | 1 |
| Bescansa, E; Cañadillas, F; Ochoa, JJ; Sánchez López, F; Viñals, M | 1 |
| Mullati, N; Satishchandra, P; Suresh, TG | 1 |
| Boyce, S; Iversen, SD; Marsden, CD; Rupniak, NM; Steventon, MJ | 1 |
| Astarloa, R; García de Yébenes, J; Mena, M | 1 |
| Balottin, U; Borgatti, R; Lanzi, G; Zambrino, CA | 1 |
| Mark, MH; Sage, JI | 1 |
| Giménez-Roldán, S | 1 |
| Quinn, NP | 1 |
| Argoff, CE; Filling-Katz, M; Fink, JK; Hallett, M; Ravin, PD | 1 |
| Bartholomé, K; Görke, W | 1 |
| Duvoisin, RC; Heikkila, RE; McHale, DM; Sage, JI; Sonsalla, PK | 1 |
| Britton, TC; Brown, P | 1 |
| Bressman, SB; Greene, PE | 1 |
| Comella, CL; Diederich, N; Goetz, CG | 1 |
| Hashimoto, S; Iwami, O; Kawamura, J; Nakamura, M; Suenaga, T | 1 |
| Boyce, S; Clarke, CE; Crossman, AR; Luquin, R; Mitchell, IJ; Peggs, D; Robertson, RG; Sambrook, MA | 1 |
| de Yebenes, JG; Fahn, S; Nygaard, TG; Trugman, JM | 1 |
| Ebi, T; Mitsuma, T; Morishima, T; Sahashi, I; Tsuchiya, I; Watanabe, K | 1 |
| McHale, DM; Sage, JI; Sonsalla, PK; Vitagliano, D | 1 |
| Kortis, HI; Sage, JI; Sommer, W | 1 |
| Matsuo, T; Sakuragawa, N; Yoshikawa, H | 1 |
| Barton, N; Burns, RS; Cohen, W; Fink, JK; Hallett, M; Lovenberg, W | 1 |
| Hashimoto, T; Maekawa, N; Oishi, T; Sasaki, M; Tsuji, S | 1 |
| Heikkila, RE; McHale, DM; Sage, JI; Sonsalla, P; Vitagliano, D | 1 |
| Boyd, K; Patterson, V | 1 |
| Fletcher, NA; Harding, AE; Holt, IJ; Mallet, J; Marsden, CD; Nygaard, TG | 1 |
| Hara, H; Kawase, J; Wakayama, Y | 1 |
| de Jong, AP; Haan, EA; Manson, JI; Ouvrier, RA; Wadman, SK; Wise, GA | 1 |
| Costeff, H; Gadoth, N; Harel, S; Lavie, P | 1 |
| Hankey, GJ; Sadka, M | 1 |
| Arens, LJ; Leary, M; Silber, MH | 1 |
| Cho, K; Kusunoki, Y; Oki, J; Sasaki, N | 1 |
| Kuroda, S; Nakashima, M; Otsuki, S; Ujike, H | 1 |
| Jenner, P; Marsden, CD; Rupniak, NM | 1 |
| Koller, WC; Lang, AE; Marsden, CD; Quinn, NP | 1 |
| Hakamada, S; Kase, M; Nagata, E; Nomura, Y; Segawa, M; Soda, M; Tanaka, S | 1 |
| Duvoisin, RC; Marsden, CD; Nygaard, TG | 1 |
| Martin, WR | 1 |
| Ishida, A; Kobayashi, Y; Takada, G; Takai, K; Toyoshima, I | 1 |
| Higashi, O; Ishida, A; Kobayashi, Y; Takada, G; Takai, K; Toyoshima, I | 1 |
| Frackowiak, RS; Leenders, KL; Marsden, CD; Quinn, N | 1 |
| Firnau, G; Garnett, ES; Lang, AE; Nahmias, C; Talalla, A | 1 |
| Lees, AJ; Poewe, WH; Stern, GM | 1 |
| Barton, NW; Cohen, WE; Filling-Katz, MR; Fink, JK; Hallett, M; Macrae, PR | 1 |
| Duvoisin, RC; Katchen, M | 1 |
| Lees, AJ; Poewe, WH | 1 |
| Aso, K; Furune, S; Negoro, T; Nomura, K; Takahashi, I; Watanabe, K; Yamamoto, N | 1 |
| Kidron, D; Melamed, E | 1 |
| Costeff, H; Gadoth, N; Harel, S; Lavie, P; Mendelson, L | 1 |
| Burns, RS; LeWitt, PA; Newman, RP | 1 |
| Klawans, HL; Paleologos, N | 1 |
| Deonna, T | 1 |
| Duvoisin, RC; Nygaard, TG | 1 |
| Kashii, H; Kihira, S; Koike, M; Shimoyamada, Y; Yoshikawa, A | 1 |
| Consroe, P; Sandyk, R; Snider, SR | 1 |
| Kase, M; Nomura, Y; Segawa, M | 1 |
| Lees, AJ; Poewe, W; Steiger, D; Stern, GM | 1 |
| Glantz, RH; Goetz, CG; Klawans, HL; Tanner, CM | 1 |
| Grau-Veciana, JM; Peiró Grasa, A | 1 |
| Jankovic, J; Pettigrew, LC | 1 |
| Bertelsmann, FW; Smit, LM | 1 |
| Bondarenko, ES; Malyshev, IuI | 1 |
| Deonna, T; Ferreira, A | 1 |
72 review(s) available for levodopa and Dystonia
| Article | Year |
|---|---|
Parkinsonism and dystonia: Clinical spectrum and diagnostic clues.
Topics: Animals; Dystonia; Dystonic Disorders; Humans; Levodopa; Movement Disorders; Parkinsonian Disorders | 2022 |
Striatal Synaptic Dysfunction in Dystonia and Levodopa-Induced Dyskinesia.
Topics: Antiparkinson Agents; Corpus Striatum; Dyskinesias; Dystonia; Dystonic Disorders; Humans; Levodopa | 2022 |
[Parkinson's Disease with Intolerable Painful Dystonia: Classification and Therapeutic Choices of Pain in Parkinson' Disease].
Topics: Antiparkinson Agents; Dystonia; Humans; Levodopa; Pain; Parkinson Disease | 2022 |
Dystonia, chorea, hemiballismus and other dyskinesias.
Topics: Chorea; Dyskinesias; Dystonia; Dystonic Disorders; Humans; Levodopa | 2022 |
Dopa-responsive dystonia, DRD-plus and DRD look-alike: a pragmatic review.
Topics: Alcohol Oxidoreductases; Biopterins; Dopamine; Dystonia; Dystonic Disorders; Humans; Levodopa | 2021 |
Pharmacological and neurosurgical interventions for individuals with cerebral palsy and dystonia: a systematic review update and meta-analysis.
Topics: Baclofen; Botulinum Toxins; Cerebral Palsy; Clonidine; Deep Brain Stimulation; Dystonia; Humans; Injections, Spinal; Levodopa; Neurosurgical Procedures; Trihexyphenidyl | 2021 |
l-Dopa in dystonia: A modern perspective.
Topics: Anti-Dyskinesia Agents; Dopamine; Dystonia; Humans; Levodopa | 2017 |
Dystonia.
Topics: Baclofen; Basal Ganglia; Botulinum Toxins, Type A; Dopamine Agents; Dystonia; Dystonic Disorders; GABA-B Receptor Agonists; GTP Cyclohydrolase; Humans; Levodopa; Neuromuscular Agents; Quality of Life | 2018 |
Dystonia and Parkinson's disease: What is the relationship?
Topics: alpha-Synuclein; Deep Brain Stimulation; Dystonia; GTP Cyclohydrolase; Humans; Levodopa; Parkinson Disease | 2019 |
The Dystonias.
Topics: Acetylcholine Release Inhibitors; Adult; Botulinum Toxins; Carbidopa; Dopamine Agonists; Drug Combinations; Dystonia; Dystonic Disorders; Female; Humans; Levodopa; Middle Aged; Physical Therapy Modalities | 2019 |
New genetic insights highlight 'old' ideas on motor dysfunction in dystonia.
Topics: Corpus Striatum; Dopamine; Dystonia; GTP-Binding Protein alpha Subunits; Humans; Levodopa; Molecular Chaperones; Mutation; TOR Serine-Threonine Kinases | 2013 |
Glutamatergic pathways as a target for the treatment of dyskinesias in Parkinson's disease.
Topics: Animals; Dyskinesias; Dystonia; Humans; Levodopa; Neurodegenerative Diseases; Parkinson Disease | 2014 |
A case of Parkinson's disease following dystonia.
Topics: Aged; Dopamine Plasma Membrane Transport Proteins; Dystonia; Female; Humans; Levodopa; Magnetic Resonance Imaging; Parkinson Disease; Radiography, Thoracic; Radionuclide Imaging | 2016 |
[Dystonia].
Topics: Cholinergic Antagonists; Deep Brain Stimulation; Dystonia; Genetic Predisposition to Disease; Humans; Levodopa; Molecular Chaperones | 2008 |
Therapeutic strategies to prevent motor complications in Parkinson's disease.
Topics: Antiparkinson Agents; Dopamine Agonists; Drug Therapy, Combination; Dyskinesia, Drug-Induced; Dystonia; Humans; Levodopa; Movement Disorders; Parkinson Disease | 2008 |
Levodopa-induced dyskinesias and their management.
Topics: Antiparkinson Agents; Chorea; Deep Brain Stimulation; Dyskinesia, Drug-Induced; Dyskinesias; Dystonia; Humans; Levodopa; Parkinson Disease; Subthalamic Nucleus | 2008 |
[Motor symptoms in Parkinson disease].
Topics: Age Factors; Antiparkinson Agents; Deep Brain Stimulation; Dopamine Agonists; Dyskinesias; Dystonia; Humans; Levodopa; Muscle Rigidity; Parkinson Disease; Selegiline; Treatment Outcome; Tremor | 2008 |
The effect of onset age on the clinical features of Parkinson's disease.
Topics: Adult; Age of Onset; Aged; Dementia; Disease Progression; Dyskinesia, Drug-Induced; Dyskinesias; Dystonia; Humans; Levodopa; Middle Aged; Parkinson Disease; Phenotype; Quality of Life; Randomized Controlled Trials as Topic; Treatment Outcome | 2009 |
Successful management of pregnancy in a patient with Segawa disease: case report and literature review.
Topics: Adult; Dopamine Agents; Dystonia; Female; Gestational Age; Humans; Levodopa; Male; Pregnancy; Pregnancy Complications; Pregnancy Outcome | 2009 |
[Medical treatment of dystonia].
Topics: Cholinergic Antagonists; Clonazepam; Diazepam; Dopamine Antagonists; Dystonia; Humans; Levodopa; Torticollis; Trihexyphenidyl | 2001 |
Treatment of Parkinson's disease: levodopa as the first choice.
Topics: Dyskinesia, Drug-Induced; Dystonia; Female; Humans; Levodopa; Male; Neuroprotective Agents; Parkinson Disease; Randomized Controlled Trials as Topic | 2002 |
Update on dopa-responsive dystonia: locus heterogeneity and biochemical features.
Topics: Antiparkinson Agents; Brain Chemistry; Dystonia; Family Health; Genetic Heterogeneity; Genetic Linkage; GTP Cyclohydrolase; Humans; Levodopa; Motor Activity; Mutation; Parkinson Disease, Secondary; Phenylketonurias; Tyrosine 3-Monooxygenase | 2004 |
Long-term L-DOPA therapy: challenges to our understanding and for the care of people with Parkinson's disease.
Topics: Antiparkinson Agents; Disease Progression; Dopamine; Dyskinesias; Dystonia; Humans; Levodopa; Long-Term Care; Parkinson Disease | 2003 |
[Genetics of dystonia].
Topics: Carrier Proteins; Dopamine Agents; Dystonia; Humans; Levodopa; Molecular Chaperones; Pedigree; Terminology as Topic | 2004 |
Profile of families with parkinsonism-predominant spinocerebellar ataxia type 2 (SCA2).
Topics: Antiparkinson Agents; Brain; Corpus Striatum; Dopamine Plasma Membrane Transport Proteins; Dystonia; Humans; Levodopa; Magnetic Resonance Imaging; Membrane Glycoproteins; Membrane Transport Proteins; Nerve Tissue Proteins; Parkinsonian Disorders; Posture; Spinocerebellar Ataxias; Tomography, Emission-Computed; Tomography, Emission-Computed, Single-Photon; Tremor | 2004 |
Long term motor complications of levodopa: clinical features, mechanisms, and management strategies.
Topics: Antiparkinson Agents; Dyskinesia, Drug-Induced; Dystonia; Forecasting; Humans; Levodopa; Parkinson Disease | 2004 |
[Medical treatment of dyskinesia].
Topics: Dyskinesia, Drug-Induced; Dystonia; Humans; Levodopa | 2004 |
Misdiagnoses in children with dopa-responsive dystonia.
Topics: Adolescent; Cerebral Palsy; Child; Child, Preschool; Diagnostic Errors; Dopamine Agents; Dystonia; Epilepsy; Female; Humans; Levodopa; Male; Spastic Paraplegia, Hereditary | 2004 |
Hyperhomocysteinemia in movement disorders: Current evidence and hypotheses.
Topics: Adolescent; Adult; Animals; Case-Control Studies; Catechol O-Methyltransferase; Cystathionine beta-Synthase; Dopamine Agents; Dystonia; Homocysteine; Humans; Huntington Disease; Hyperhomocysteinemia; Levodopa; Methylenetetrahydrofolate Reductase (NADPH2); Middle Aged; Movement Disorders; Parkinson Disease; Prospective Studies | 2006 |
[The dystonias--botulinum toxin, deep brain stimulation, pharmacotherapy, motor training].
Topics: Adolescent; Adult; Antiparkinson Agents; Botulinum Toxins, Type A; Child; Cholinergic Antagonists; Clinical Trials as Topic; Deep Brain Stimulation; Dopamine Agents; Double-Blind Method; Drug Therapy, Combination; Dystonia; Electric Stimulation; Electromyography; Humans; Levodopa; Magnetic Resonance Imaging; Neuromuscular Agents; Neurotoxins; Occupational Therapy; Physical Therapy Modalities; Practice Guidelines as Topic; Psychotherapy; Tomography, X-Ray Computed; Ultrasonography | 2007 |
Paradoxes of functional neurosurgery: clues from basal ganglia recordings.
Topics: Antiparkinson Agents; Basal Ganglia; Deep Brain Stimulation; Dyskinesia, Drug-Induced; Dystonia; Essential Tremor; Globus Pallidus; Humans; Levodopa; Movement Disorders; Neurosurgical Procedures; Parkinson Disease | 2008 |
[L-dopa-responsive dystonia: 2 familial cases of adult onset with sleep disorders].
Topics: Adult; Dystonia; Female; Humans; Levodopa; Male; Middle Aged; Sleep Wake Disorders | 1995 |
Dopa-responsive dystonia.
Topics: Child, Preschool; Chromosome Aberrations; Chromosome Disorders; Corpus Striatum; Diagnosis, Differential; DNA Mutational Analysis; Dystonia; Genes, Dominant; GTP Cyclohydrolase; Humans; Infant; Levodopa; Neural Pathways; Parkinson Disease, Secondary; Phenotype; Spinal Cord; Substantia Nigra | 1995 |
Dopa-responsive dystonia.
Topics: Adult; Carbidopa; Drug Therapy, Combination; Dystonia; Female; Humans; Levodopa; Tablets | 1994 |
[Hereditary progressive dystonia with marked diurnal fluctuation (HPD)].
Topics: Circadian Rhythm; Corpus Striatum; Diagnosis, Differential; Dopamine; Dystonia; Humans; Levodopa; Substantia Nigra; Tyrosine 3-Monooxygenase | 1993 |
[Clinical aspects on juvenile parkinsonism].
Topics: Adolescent; Adult; Child; Dystonia; Female; Genes, Dominant; Genes, Recessive; Humans; Levodopa; Male; Parkinson Disease | 1994 |
[Dystonia].
Topics: Adolescent; Adult; Botulinum Toxins; Dystonia; Female; Humans; Levodopa; Male; Middle Aged; Parasympatholytics | 1993 |
[Oral dyskinesis, facial dystonia].
Topics: Dyskinesia, Drug-Induced; Dystonia; Face; Female; Humans; Levodopa; Male; Meige Syndrome; Mouth; Movement Disorders; Receptors, Dopamine D1; Sulpiride; Tiapamil Hydrochloride; Trihexyphenidyl | 1993 |
Dystonia and Parkinson's disease.
Topics: Diagnosis, Differential; Dose-Response Relationship, Drug; Dystonia; Humans; Levodopa; Long-Term Care; Neurologic Examination; Parkinson Disease | 1993 |
Hereditary progressive dystonia with marked diurnal fluctuation. Pathophysiological importance of the age of onset.
Topics: Adolescent; Adult; Age Factors; Basal Ganglia; Brain Stem; Child; Circadian Rhythm; Dystonia; Female; Follow-Up Studies; Humans; Levodopa; Male; Parkinson Disease; Parkinson Disease, Secondary; Sex Factors; Sleep Stages | 1993 |
Dopa-responsive dystonia. Delineation of the clinical syndrome and clues to pathogenesis.
Topics: Adolescent; Adult; Child; Diagnosis, Differential; Dystonia; Female; Humans; Levodopa; Male; Neurologic Examination; Parkinson Disease; Parkinson Disease, Secondary; Phenotype | 1993 |
Dopa-responsive dystonia: a widening spectrum.
Topics: Child; Dystonia; Humans; Levodopa; Parkinson Disease | 1996 |
[Pathophysiologies of dystonia and myoclonus--consideration from the standpoint of treatment].
Topics: Age of Onset; Animals; Dystonia; Epilepsy; Humans; Levodopa; Myoclonus | 1995 |
[Pharmacological therapy of complicated Parkinson's disease].
Topics: Antiparkinson Agents; Ascorbic Acid; Combined Modality Therapy; Diet Therapy; Dose-Response Relationship, Drug; Drug Therapy, Combination; Dyskinesia, Drug-Induced; Dystonia; Humans; Levodopa; Parkinson Disease | 1997 |
Dopa-responsive dystonia: a syndrome of selective nigrostriatal dopaminergic deficiency.
Topics: Adult; Age of Onset; Child; Corpus Striatum; Diagnosis, Differential; Dopamine; Dystonia; Female; Humans; Levodopa; Substantia Nigra; Syndrome | 1997 |
Molecular and biochemical aspects of hereditary progressive and dopa-responsive dystonia.
Topics: Brain Chemistry; Dopamine Agents; Dystonia; Humans; Levodopa | 1998 |
Tetrahydrobiopterin metabolism and GTP cyclohydrolase I mutations in L-dopa-responsive dystonia.
Topics: Biopterins; Dopamine Agents; Dystonia; GTP Cyclohydrolase; Humans; Levodopa; Mutation | 1998 |
Defects of biopterin metabolism and biogenic amine biosynthesis: clinical diagnostic, and therapeutic aspects.
Topics: Biogenic Amines; Biopterins; Dopamine Agents; Dystonia; Humans; Levodopa | 1998 |
PET measurements of dopaminergic pathways in the brain.
Topics: Adrenergic Fibers; Brain Diseases; Cerebrovascular Circulation; Dopamine; Dopamine Agents; Dystonia; Humans; Levodopa; Neural Pathways; Parkinson Disease; Radiopharmaceuticals; Receptors, Dopamine; Schizophrenia; Tomography, Emission-Computed | 1999 |
[Hereditary progressive dystonia with marked diurnal fluctuation; dominant Dopa-responsive dystonia linked to GTP cyclohydrolase I gene (HPD/DRD); Segawa's disease].
Topics: Circadian Rhythm; Diagnosis, Differential; Dopamine Agents; Dystonia; GTP Cyclohydrolase; Humans; Levodopa; Prognosis | 1999 |
Dopa-responsive dystonia: recent advances and remaining issues to be addressed.
Topics: Antiparkinson Agents; Biopterins; DNA, Recombinant; Dystonia; Female; GTP Cyclohydrolase; Humans; Levodopa; Male; Penetrance; Phenotype; Point Mutation; Syndrome | 1999 |
Molecular genetics of dopa-responsive dystonia.
Topics: Dystonia; Genes, Dominant; Genes, Recessive; Humans; Levodopa; Tyrosine 3-Monooxygenase | 1999 |
Bromocriptine for levodopa-induced motor complications in Parkinson's disease.
Topics: Antiparkinson Agents; Bromocriptine; Dyskinesia, Drug-Induced; Dystonia; Humans; Levodopa; Parkinson Disease | 2000 |
Hereditary progressive dystonia with marked diurnal fluctuation.
Topics: Animals; Brain; Dystonia; Dystonic Disorders; Humans; Levodopa; Neural Pathways; Tomography, Emission-Computed | 2000 |
Treatment of Parkinson's disease.
Topics: Age Factors; Animals; Antiparkinson Agents; Anxiety; Catechol O-Methyltransferase Inhibitors; Depression; Dopamine Agonists; Dyskinesia, Drug-Induced; Dystonia; Humans; Levodopa; Parkinson Disease | 2000 |
Dystonia: an update on genetics and treatment.
Topics: Adult; Botulinum Toxins, Type A; Carrier Proteins; Child; Chromosome Mapping; Combined Modality Therapy; Dystonia; Humans; Levodopa; Molecular Chaperones; Phenotype | 2001 |
Dystonia and parkinsonism.
Topics: Antiparkinson Agents; Dystonia; Humans; Levodopa; Parkinsonian Disorders; Syndrome | 2001 |
Use of selective thalamotomy for various kinds of movement disorder, based on basic studies.
Topics: Antiparkinson Agents; Cerebral Hemorrhage; Chorea; Dyskinesia, Drug-Induced; Dyskinesias; Dystonia; Electrodes, Implanted; Electroencephalography; Female; Humans; Levodopa; Magnetic Resonance Imaging; Male; Movement Disorders; Muscle Rigidity; Paresthesia; Parkinson Disease; Postoperative Complications; Stereotaxic Techniques; Surgery, Computer-Assisted; Thalamic Nuclei; Tomography, X-Ray Computed; Treatment Outcome; Tremor | 2000 |
The pathogensis and medical treatment of extrapyramidal disease.
Topics: Adult; Athetosis; Basal Ganglia Diseases; Caudate Nucleus; Chorea; Corpus Striatum; Dopamine; Dopamine Antagonists; Drug Administration Schedule; Dystonia; Female; gamma-Aminobutyric Acid; Glutamates; Haloperidol; Humans; Huntington Disease; Levodopa; Male; Middle Aged; Movement Disorders; Parkinson Disease; Tic Disorders | 1979 |
[Dopa-sensitive dystonia].
Topics: Carbidopa; Child; Child, Preschool; Dystonia; Female; Follow-Up Studies; Homovanillic Acid; Humans; Infant; Levodopa; Male | 1992 |
The dystonias.
Topics: Animals; Basal Ganglia; Botulinum Toxins; Cebus; Chromosomes, Human, Pair 9; Disease Models, Animal; Dystonia; Dystonia Musculorum Deformans; Humans; Injections, Intramuscular; Levodopa; Magnetic Resonance Imaging; Muscle Contraction; Muscles; Neurologic Examination; Tomography, Emission-Computed; Tomography, X-Ray Computed | 1992 |
[Physiopathology of dystonia].
Topics: Animals; Basal Ganglia; Brain Stem; Central Nervous System Diseases; Disease Models, Animal; Dopamine; Dystonia; Humans; Levodopa; Metabolism, Inborn Errors; Models, Neurological; Norepinephrine; Rats; Synaptic Transmission | 1991 |
[Advances in the treatment of the dystonias].
Topics: Blepharospasm; Botulinum Toxins; Dystonia; Dystonia Musculorum Deformans; Humans; Levodopa; Parasympatholytics; Stereotaxic Techniques; Thalamus | 1991 |
Treatment of hyperkinetic movement disorders.
Topics: Benzodiazepines; Clonidine; Dystonia; Humans; Levodopa; Movement Disorders | 1990 |
New approaches in the treatment of the dystonias.
Topics: Botulinum Toxins; Diagnosis, Differential; Dopamine Antagonists; Dystonia; Humans; Levodopa; Neuromuscular Diseases; Neurosurgery; Parasympatholytics | 1990 |
Acute dystonia induced by neuroleptic drugs.
Topics: Acute Disease; alpha-Methyltyrosine; Animals; Antipsychotic Agents; Brain; Chlorpromazine; Disease Models, Animal; Drug Synergism; Dystonia; Fluphenazine; Haloperidol; Histamine H1 Antagonists; Levodopa; Mastication; Methyltyrosines; Movement Disorders; Parasympatholytics; Physostigmine; Primates; Rats | 1986 |
Hereditary progressive dystonia with marked diurnal fluctuation--consideration on its pathophysiology based on the characteristics of clinical and polysomnographical findings.
Topics: Age Factors; Child; Circadian Rhythm; Dystonia; Dystonia Musculorum Deformans; Humans; Levodopa; Movement; Neck Muscles; Posture; Sleep | 1988 |
Dopamine agonists and antagonists in the treatment of idiopathic dystonia.
Topics: Animals; Circadian Rhythm; Dopamine; Dopamine Antagonists; Dystonia; Humans; Levodopa; Parkinson Disease, Secondary | 1988 |
Dopa-responsive dystonia.
Topics: Adolescent; Child; Child, Preschool; Circadian Rhythm; Diagnosis, Differential; Dystonia; Female; Humans; Infant; Levodopa; Male; Posture; Sleep | 1988 |
Positron emission tomography in movement disorders.
Topics: Brain; Cerebrovascular Circulation; Corpus Striatum; Dihydroxyphenylalanine; Dopamine; Dystonia; Glucose; Humans; Huntington Disease; Levodopa; Movement Disorders; Oxygen Consumption; Parkinson Disease; Synapses; Tomography, Emission-Computed | 1985 |
The pharmacology of foot dystonia in parkinsonism.
Topics: Dystonia; Foot Diseases; Humans; Levodopa; Parkinson Disease | 1987 |
Dopamine agonists in the treatment of dystonia.
Topics: Circadian Rhythm; Dystonia; Dystonia Musculorum Deformans; Humans; Levodopa; Lisuride; Receptors, Dopamine; Torticollis | 1985 |
10 trial(s) available for levodopa and Dystonia
| Article | Year |
|---|---|
GCH1 mutation and clinical study of Chinese patients with dopa-responsive dystonia.
Topics: Adolescent; Adult; Asian People; Child; Child, Preschool; DNA Mutational Analysis; DNA Primers; Dopamine Agonists; Dystonia; Exons; Female; GTP Cyclohydrolase; Humans; Infant; Levodopa; Male; Pedigree; Point Mutation; Polymerase Chain Reaction; Young Adult | 2010 |
The phenylalanine loading test in the differential diagnosis of dystonia.
Topics: Administration, Oral; Adult; Diagnosis, Differential; Dystonia; Female; Humans; Levodopa; Male; Middle Aged; Phenylalanine; Predictive Value of Tests; Reference Values; Sensitivity and Specificity; Time Factors; Tyrosine | 2003 |
Spontaneous pallidal neuronal activity in human dystonia: comparison with Parkinson's disease and normal macaque.
Topics: Action Potentials; Adolescent; Adult; Aged; Animals; Antiparkinson Agents; Dystonia; Electromyography; Female; Globus Pallidus; Humans; Levodopa; Macaca; Male; Middle Aged; Neurons; Parkinson Disease; Severity of Illness Index; Time Factors | 2005 |
Efficacy and safety of high-dose cabergoline in Parkinson's disease.
Topics: Adolescent; Adult; Aged; Amantadine; Antiparkinson Agents; Cabergoline; Catechols; Drug Therapy, Combination; Dyskinesia, Drug-Induced; Dystonia; Ergolines; Humans; Levodopa; Middle Aged; Nitriles; Parkinson Disease; Piperidines; Prospective Studies; Quality of Life; Selegiline; Severity of Illness Index; Treatment Outcome | 2006 |
Distinguishing early-onset PD from dopa-responsive dystonia with transcranial sonography.
Topics: Adult; Age of Onset; Antiparkinson Agents; Diagnosis, Differential; Dystonia; Female; Humans; In Vitro Techniques; Levodopa; Middle Aged; Parkinson Disease; Reproducibility of Results; Sensitivity and Specificity; Ultrasonography, Doppler, Transcranial | 2006 |
Early combination therapy (bromocriptine and levodopa) does not prevent motor fluctuations in Parkinson's disease.
Topics: Activities of Daily Living; Aged; Bromocriptine; Chorea; Double-Blind Method; Drug Therapy, Combination; Dystonia; Female; Humans; Levodopa; Male; Middle Aged; Motor Skills; Parkinson Disease | 1993 |
[L-dopa and bromocriptine in Parkinson disease. Early combination therapy has better effect].
Topics: Bromocriptine; Drug Therapy, Combination; Dystonia; Female; Humans; Hyperkinesis; Levodopa; Male; Motor Activity; Parkinson Disease; Time Factors | 1993 |
Early-onset parkinsonism with dystonia. Clinical and biochemical differences from hereditary progressive dystonia or DOPA-responsive dystonia.
Topics: Adolescent; Adult; Age of Onset; Aged; Antiparkinson Agents; Biopterins; Child; Child, Preschool; Diagnosis, Differential; Dystonia; Female; Genetic Linkage; Humans; Levodopa; Male; Middle Aged; Neopterin; Parkinson Disease; Tremor | 1996 |
Motor fluctuations in Parkinson's disease.
Topics: Adult; Aged; Aged, 80 and over; Antiparkinson Agents; Disease Progression; Dystonia; Female; Humans; Levodopa; Male; Middle Aged; Movement; Movement Disorders; Parkinson Disease; Risk Factors | 1999 |
Morphine in tardive and idiopathic dystonia (short communication).
Topics: Adult; Aged; Dose-Response Relationship, Drug; Dyskinesia, Drug-Induced; Dystonia; Female; Humans; Levodopa; Middle Aged; Morphine; Neostriatum; Pain; Parkinson Disease; Pilot Projects; Receptors, Dopamine; Treatment Outcome | 2001 |
330 other study(ies) available for levodopa and Dystonia
| Article | Year |
|---|---|
L-Dopa response, choreic dyskinesia, and dystonia in Perry syndrome.
Topics: Antiparkinson Agents; Depression; Dyskinesia, Drug-Induced; Dystonia; Dystonic Disorders; Humans; Hypoventilation; Levodopa; Parkinson Disease; Parkinsonian Disorders | 2022 |
Generalised dystonic presentation of CACNA1B-associated dystonia and its response to Levodopa.
Topics: Calcium Channels, N-Type; Dystonia; Dystonic Disorders; Humans; Levodopa | 2023 |
Neurodevelopmental disorder with dystonia due to SOX6 mutations.
Topics: Dystonia; Dystonic Disorders; Facial Asymmetry; Humans; Levodopa; Musculoskeletal Abnormalities; Mutation; Neurodevelopmental Disorders; SOXD Transcription Factors; Tremor | 2022 |
Pearls & Oy-sters: SCA21 Due to
Topics: alpha-Fetoproteins; Dystonia; Dystonic Disorders; Humans; Levodopa; Membrane Proteins; Myoclonus; Spinocerebellar Degenerations | 2022 |
Striatal Subregion-selective Dysregulated Dopamine Receptor-mediated Intracellular Signaling in a Model of DOPA-responsive Dystonia.
Topics: Animals; Corpus Striatum; Dopamine; Dopamine Antagonists; Dystonia; Extracellular Signal-Regulated MAP Kinases; Levodopa; Mice; Parkinsonian Disorders; Receptors, Dopamine D1 | 2023 |
[Clinical and genetic characteristics of children with dopa-responsive dystonia caused by tyrosine hydroxylase gene variations].
Topics: Benserazide; Dystonia; Female; Humans; Hypokinesia; Infant; Levodopa; Male; Muscle Hypotonia; Retrospective Studies; Tyrosine 3-Monooxygenase | 2023 |
Dystonic Cerebral Palsy Phenotype Due to GNAO1 Variant Responsive to Levodopa.
Topics: Cerebral Palsy; Dopamine Agents; Dystonia; GTP-Binding Protein alpha Subunits, Gi-Go; Heterozygote; Humans; Levodopa; Male; Phenotype; Young Adult | 2023 |
Dopa-responsive dystonia in spinocerebellar ataxia 6: A case report.
Topics: Aged; Cerebellar Ataxia; Dystonia; Female; Humans; Levodopa; Spinocerebellar Ataxias | 2023 |
Comparison of dyskinesia profiles after L-DOPA dose challenges with or without dopamine agonist coadministration.
Topics: Antiparkinson Agents; Dopamine Agonists; Dyskinesia, Drug-Induced; Dystonia; Humans; Hyperkinesis; Levodopa; Oxidopamine; Parkinson Disease | 2023 |
Orofacial dystonia and asssociated bulbar symptoms in multiple system atrophy: A blinded video analysis.
Topics: Dystonia; Dystonic Disorders; Humans; Levodopa; Movement Disorders; Multiple System Atrophy | 2020 |
Early morning off in patients with Parkinson's disease: a Chinese nationwide study and a 7-question screening scale.
Topics: Aged; China; Dystonia; Fatigue; Female; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Registries; Surveys and Questionnaires | 2020 |
Dramatic Response to Pramipexole in Delayed-Onset Parkinsonism from Osmotic Demyelinating Syndrome.
Topics: Adult; Antiparkinson Agents; Deamino Arginine Vasopressin; Demyelinating Diseases; Dystonia; Epistaxis; Hemostatics; Humans; Hyponatremia; Levodopa; Locked-In Syndrome; Male; Myelinolysis, Central Pontine; Osmotic Pressure; Parkinsonian Disorders; Postoperative Hemorrhage; Pramipexole; Pseudobulbar Palsy; Rhinoplasty; Tetrahydronaphthalenes; Thiophenes; Treatment Failure; Treatment Outcome; von Willebrand Disease, Type 1 | 2020 |
Levodopa responsive-generalized dystonic spells and moaning in DNAJC6 related Juvenile Parkinson's disease.
Topics: Adolescent; Dopamine Agents; Dystonia; HSP40 Heat-Shock Proteins; Humans; Levodopa; Male; Parkinson Disease | 2020 |
NR4A2 and Dystonia with Dopa Responsiveness.
Topics: Dystonia; Dystonic Disorders; Humans; Infant; Levodopa; Male; Nuclear Receptor Subfamily 4, Group A, Member 2 | 2021 |
Clinical pearls and scientific advancement: Reconciling tradition with new knowledge.
Topics: Dystonia; Dystonic Disorders; Humans; Knowledge; Levodopa | 2017 |
Inhibitory Basal Ganglia Inputs Induce Excitatory Motor Signals in the Thalamus.
Topics: Action Potentials; Alcohol Oxidoreductases; Animals; Calcium Channels, T-Type; Dopamine; Dystonia; Female; Globus Pallidus; Levodopa; Male; Metabolism, Inborn Errors; Mice; Mice, Knockout; Motor Neurons; Muscle Contraction; Neural Inhibition; Neural Pathways; Neurons; Psychomotor Disorders; Thalamus | 2017 |
Case 38-2017. A 20-Year-Old Woman with Seizures and Progressive Dystonia.
Topics: Basal Ganglia Diseases; Biotin; Brain; Carbidopa; Diagnosis, Differential; Drug Combinations; Dystonia; Female; Humans; Levodopa; Macula Lutea; Magnetic Resonance Imaging; Membrane Transport Proteins; Metabolism, Inborn Errors; Mutation; Optic Nerve; Seizures; Thiamine; Young Adult | 2017 |
Reader response: l-Dopa in dystonia: A modern perspective.
Topics: Dystonia; Dystonic Disorders; Humans; Levodopa | 2018 |
Author response: l-Dopa in dystonia: A modern perspective.
Topics: Dystonia; Dystonic Disorders; Humans; Levodopa | 2018 |
Levodopa-induced dystonia in a patient with possible progressive supranuclear palsy with progressive gait freezing.
Topics: Aged; Diagnosis, Differential; Dopamine Agents; Dystonia; Female; Gait Disorders, Neurologic; Humans; Levodopa; Supranuclear Palsy, Progressive | 2018 |
Dystonia.
Topics: Botulinum Toxins, Type A; Dystonia; Humans; Levodopa; Neuromuscular Agents; Quality of Life | 2018 |
Craniocervical dystonia with levodopa-responsive parkinsonism co-segregating with a pathogenic ANO3 mutation in a Taiwanese family.
Topics: Anoctamins; Cervical Vertebrae; Dystonia; Female; Genetic Variation; Humans; Levodopa; Male; Middle Aged; Mutation; Parkinsonian Disorders; Pedigree; Skull; Taiwan; Young Adult | 2019 |
[Dopaminergic drug-induced jaw-opening dystonia in a patient with progressive supranuclear palsy].
Topics: Aged; Dopamine Agents; Dystonia; Humans; Levodopa; Male; Mandibular Diseases; Supranuclear Palsy, Progressive | 2013 |
Pisa syndrome in Parkinson's disease: an electrophysiological and imaging study.
Topics: Aged; Aged, 80 and over; Antiparkinson Agents; Atrophy; Dystonia; Electromyography; Female; Humans; Levodopa; Magnetic Resonance Imaging; Male; Middle Aged; Paraspinal Muscles; Parkinson Disease; Posture; Radiography; Spine; Thorax | 2013 |
Mutation in the SYNJ1 gene associated with autosomal recessive, early-onset Parkinsonism.
Topics: Adolescent; Adult; Age of Onset; Auxilins; Child; Cognition Disorders; Consanguinity; Dystonia; Exome; Female; Genes, Recessive; Genetic Variation; Homozygote; Humans; Italy; Levodopa; Male; Middle Aged; Mutation; Parkinsonian Disorders; Pedigree; Phosphoric Monoester Hydrolases; Radiography; Sequence Analysis, DNA; Young Adult | 2013 |
Brief case report: dopa-responsive dystonia.
Topics: Adult; Carbidopa; Dopamine Agonists; Drug Combinations; Dystonia; Female; Humans; Insurance, Life; Levodopa | 2013 |
Asymmetrical leg atrophy in levodopa-responsive dystonia due to a novel GTP cyclohydrolase mutation.
Topics: Adult; Atrophy; Dystonia; Genetic Predisposition to Disease; Genetic Testing; GTP Cyclohydrolase; Humans; Leg; Levodopa; Male; Mutation | 2014 |
Teaching NeuroImages: Pisa syndrome in Parkinson disease.
Topics: Aged; Carbidopa; Drug Combinations; Dystonia; Humans; Indoles; Levodopa; Male; Parkinson Disease; Posture; Scoliosis | 2014 |
Levodopa-induced lateral jaw deviation dystonia.
Topics: Aged; Dystonia; Female; Humans; Jaw; Levodopa | 2015 |
A new knock-in mouse model of l-DOPA-responsive dystonia.
Topics: Animals; Benzazepines; Brain; Catecholamines; Disease Models, Animal; Dopamine Agents; Dopamine Antagonists; Dopamine Plasma Membrane Transport Proteins; Dystonia; Humans; Levodopa; Mice; Mice, Inbred C57BL; Mice, Transgenic; Motor Activity; Mutation; Radionuclide Imaging; Stereotyped Behavior; Tritium; Tyrosine 3-Monooxygenase | 2015 |
Pisa syndrome in Parkinson disease: An observational multicenter Italian study.
Topics: Aged; Cohort Studies; Cross-Sectional Studies; Dopamine Agonists; Dystonia; Female; Humans; Italy; Levodopa; Male; Middle Aged; Parkinson Disease; Syndrome | 2015 |
Medication use in childhood dystonia.
Topics: Adolescent; Antiparkinson Agents; Baclofen; Child; Chloral Hydrate; Cohort Studies; Diazepam; Drug-Related Side Effects and Adverse Reactions; Dystonia; Dystonic Disorders; Female; Humans; Hypnotics and Sedatives; Levodopa; Logistic Models; Male; Muscle Relaxants, Central; Risk Factors; Trihexyphenidyl | 2016 |
What Is Not in the Name? Dopa-Responsive Dystonia May Respond to More Than L-Dopa.
Topics: 5-Hydroxytryptophan; Adolescent; Anti-Dyskinesia Agents; Carbidopa; Diseases in Twins; Dopamine Agonists; Drug Combinations; Dystonia; Female; Humans; Levodopa; Male; Metabolism, Inborn Errors; Psychomotor Disorders; Serotonin Agents | 2016 |
Flamenco dancer posture: Unique "off" complication in Parkinson disease.
Topics: Aged; Antiparkinson Agents; Dystonia; Humans; Levodopa; Male; Parkinson Disease | 2016 |
Dementia with Lewy bodies presenting marked tongue protrusion and bite due to lingual dystonia: A case report.
Topics: Acute Disease; Antipsychotic Agents; Benzodiazepines; Bites and Stings; Drug Interactions; Drug Therapy, Combination; Dyskinesia, Drug-Induced; Dystonia; Female; Humans; Indoles; Laryngeal Diseases; Levodopa; Lewy Body Disease; Middle Aged; Olanzapine; Receptors, Dopamine D1; Tetrahydronaphthalenes; Thiophenes; Tongue Diseases | 2016 |
Classification of dopa-responsive dystonia - a patient's perspective.
Topics: Dystonia; Dystonic Disorders; Humans; Levodopa | 2016 |
Status dystonicus in children: Early recognition and treatment prevent serious complications.
Topics: Adolescent; Anti-Dyskinesia Agents; Athetosis; Baclofen; Cerebral Palsy; Child; Disease Progression; Dystonia; Female; Fluid Therapy; Humans; Infections; Levodopa; Male; Muscle Relaxants, Central; Retrospective Studies; Treatment Outcome | 2016 |
Subthalamic oscillatory activity in parkinsonian patients with off-period dystonia.
Topics: Adult; Aged; Dyskinesia, Drug-Induced; Dystonia; Electroencephalography; Electromyography; Female; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Subthalamic Nucleus | 2016 |
Tor1a+/- mice develop dystonia-like movements via a striatal dopaminergic dysregulation triggered by peripheral nerve injury.
Topics: Animals; Corpus Striatum; Dopamine; Dopamine Agents; Dopamine Plasma Membrane Transport Proteins; Dystonia; Gait; Hindlimb; Homeostasis; Levodopa; Mice, 129 Strain; Mice, Inbred C57BL; Mice, Knockout; Molecular Chaperones; Motor Activity; Peripheral Nerve Injuries; Receptors, Dopamine D1; Receptors, Dopamine D2; Sciatic Nerve | 2016 |
Lingual protrusion dystonia: Manifestation during "on" periods in Parkinson's disease.
Topics: Aged, 80 and over; Antiparkinson Agents; Botulinum Toxins, Type A; Diagnosis, Differential; Dystonia; Humans; Levodopa; Male; Neuromuscular Agents; Parkinson Disease; Tongue Diseases | 2016 |
Pallidal Deep Brain Stimulation for the Treatment of Levodopa-Responsive Juvenile Dystonia and Parkinsonism Secondary to SPG11 Mutation.
Topics: Action Potentials; Antiparkinson Agents; Deep Brain Stimulation; Dystonia; Female; Globus Pallidus; Humans; Levodopa; Magnetic Resonance Imaging; Mutation; Neurons; Parkinsonian Disorders; Proteins; Treatment Outcome; Young Adult | 2017 |
Correspondence: The pathophysiology of pramipexole-associated dystonia in patients with Parkinson's disease.
Topics: Antiparkinson Agents; Benzothiazoles; Dopamine Agonists; Dystonia; Humans; Levodopa; Parkinson Disease; Pramipexole | 2017 |
Molecular analyses of GCH-1, TH and parkin genes in Chinese dopa-responsive dystonia families.
Topics: Adolescent; Adult; Aged; Asian People; Benserazide; Child; Child, Preschool; Dopamine Agents; Drug Combinations; Dystonia; Female; Genetic Variation; GTP Cyclohydrolase; Humans; Levodopa; Male; Middle Aged; Mutation; Pedigree; Tyrosine 3-Monooxygenase; Ubiquitin-Protein Ligases; Young Adult | 2008 |
Mitochondrial diseases mimicking neurotransmitter defects.
Topics: Alanine; Brain; Child, Preschool; Consanguinity; Diagnosis, Differential; Dopamine Agents; Dystonia; Electron Transport Complex I; Electron Transport Complex II; Electron Transport Complex III; Female; Homovanillic Acid; Humans; Hydroxyindoleacetic Acid; Infant; Infant, Newborn; Lactic Acid; Levodopa; Male; Mitochondrial Diseases; Neurotransmitter Agents; Pterins; Radiography; Treatment Outcome | 2008 |
Segawa disease with a novel heterozygous mutation in exon 5 of the GCH-1 gene (E183K).
Topics: Base Sequence; Biopterins; Child; Dystonia; Dystonic Disorders; Exons; Female; GTP Cyclohydrolase; Heterozygote; Humans; Levodopa; Male; Mutation, Missense; Neopterin; Pedigree; Sequence Analysis, DNA | 2009 |
Late onset dopa-responsive dystonia with tremor, gait freezing and behavioural disturbance and a normal dopamine transporter scan.
Topics: Aged; Antiparkinson Agents; Benzothiazoles; Diagnosis, Differential; Dopamine Agents; Drug Therapy, Combination; Dystonia; Female; Gait Disorders, Neurologic; Humans; Levodopa; Pramipexole; Tremor | 2008 |
Anaesthesia for caesarean section in a patient with dopa-responsive dystonia or Segawa's syndrome.
Topics: Adult; Anesthesia, Epidural; Anesthesia, Obstetrical; Anesthesia, Spinal; Antiparkinson Agents; Cesarean Section; Dystonia; Female; Humans; Levodopa; Pregnancy; Pregnancy Complications; Syndrome; Treatment Outcome | 2009 |
Clinical features of dystonia in atypical parkinsonism.
Topics: Adult; Aged; Antiparkinson Agents; Cerebral Cortex; Dystonia; Female; Humans; Levodopa; Magnetic Resonance Imaging; Male; Middle Aged; Multiple System Atrophy; Nerve Degeneration; Parkinsonian Disorders; Supranuclear Palsy, Progressive | 2008 |
"Jerky" dystonia in children: spectrum of phenotypes and genetic testing.
Topics: Adolescent; Adult; Age of Onset; Anticonvulsants; Antiparkinson Agents; Child; Child, Preschool; DNA Mutational Analysis; Dystonia; Exons; Female; Genetic Testing; Genotype; Humans; Hyperkinesis; Levodopa; Longitudinal Studies; Male; Middle Aged; Muscle, Skeletal; Mutation; Myoclonus; Nuclear Proteins; Phenotype; Sarcoglycans; Severity of Illness Index; Thyroid Nuclear Factor 1; Transcription Factors; Tyrosine; Young Adult | 2009 |
Sepiapterin reductase deficiency in a 2-year-old girl with incomplete response to treatment during short-term follow-up.
Topics: 5-Hydroxytryptophan; Alcohol Oxidoreductases; Biogenic Amines; Child, Preschool; Dystonia; Female; Follow-Up Studies; Homozygote; Humans; Levodopa; Metabolism, Inborn Errors; Mutation, Missense; Psychomotor Disorders | 2009 |
Responsiveness to levodopa in epsilon-sarcoglycan deletions.
Topics: Adolescent; Antiparkinson Agents; Child; Dystonia; Female; Gene Deletion; Humans; Levodopa; Male; Myoclonus; Sarcoglycans | 2009 |
[Dopa-responsive dystonia].
Topics: Adolescent; Adult; Aged; Diagnosis, Differential; Dystonia; GTP Cyclohydrolase; Humans; Levodopa; Middle Aged; Mutation; Pedigree; Point Mutation; Sequence Deletion | 2009 |
Reversible Pisa syndrome in patients with Parkinson's disease on dopaminergic therapy.
Topics: Aged; Aged, 80 and over; Benserazide; Benzothiazoles; Brain; Carbidopa; Dopamine Agents; Dystonia; Female; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Pergolide; Pramipexole; Severity of Illness Index; Time Factors; Tomography, Emission-Computed, Single-Photon; Tropanes | 2009 |
Autosomal-dominant GTPCH1-deficient DRD: clinical characteristics and long-term outcome of 34 patients.
Topics: Adolescent; Adult; Age of Onset; Aged; Aged, 80 and over; Cohort Studies; Comorbidity; Disease Progression; Dopamine Agents; Dystonia; Female; GTP Cyclohydrolase; Hormones; Humans; Levodopa; Long-Term Care; Male; Mental Disorders; Middle Aged; Mutation; Treatment Outcome; Young Adult | 2009 |
Cases of dopa-responsive dystonia (Segawa disease) in Estonia.
Topics: Adolescent; Child; Child, Preschool; Dystonia; Estonia; Female; Humans; Levodopa; Male; Treatment Outcome | 2010 |
Reduced levodopa-induced complications after 5 years of subthalamic stimulation in Parkinson's disease: a second honeymoon.
Topics: Antiparkinson Agents; Deep Brain Stimulation; Dyskinesia, Drug-Induced; Dystonia; Follow-Up Studies; Humans; Levodopa; Parkinson Disease; Severity of Illness Index; Subthalamic Nucleus | 2009 |
Levodopa responsive dystonia secondary to virus encephalitis.
Topics: Adolescent; Anti-Dyskinesia Agents; Dystonia; Encephalitis, Arbovirus; Female; Humans; Levodopa; Treatment Outcome | 2009 |
Novel non-sense GCH1 mutation in a South African family diagnosed with dopa-responsive dystonia.
Topics: Adolescent; Adult; Age of Onset; Aged; Anti-Dyskinesia Agents; Base Sequence; Child; Child, Preschool; Codon, Nonsense; Dystonia; Exons; Family; Female; Humans; Levodopa; Male; Middle Aged; Pedigree; South Africa; Young Adult | 2010 |
Metabotropic glutamate mGluR5 receptor blockade opposes abnormal involuntary movements and the increases in glutamic acid decarboxylase mRNA levels induced by l-DOPA in striatal neurons of 6-hydroxydopamine-lesioned rats.
Topics: Adrenergic Agents; Animals; Corpus Striatum; Dopamine Agents; Dynorphins; Dyskinesia, Drug-Induced; Dystonia; Excitatory Amino Acid Antagonists; Glutamate Decarboxylase; Levodopa; Male; Neurons; Oxidopamine; Protein Precursors; Pyridines; Random Allocation; Rats; Rats, Sprague-Dawley; Receptor, Metabotropic Glutamate 5; Receptors, Metabotropic Glutamate; RNA, Messenger | 2009 |
Low-dose levodopa is effective for laryngeal dystonia in xeroderma pigmentosum group A.
Topics: Adolescent; Dopamine Agents; Dystonia; Female; Humans; Laryngeal Diseases; Larynx; Levodopa; Male; Xeroderma Pigmentosum | 2010 |
Levodopa responsive hemidystonia associated with contralateral nigral lesion.
Topics: Anti-Dyskinesia Agents; Brain Diseases; Dystonia; Female; Functional Laterality; Humans; Levodopa; Magnetic Resonance Imaging; Middle Aged; Positron-Emission Tomography; Substantia Nigra; Tropanes | 2010 |
Familial paroxysmal exercise-induced dystonia: atypical presentation of autosomal dominant GTP-cyclohydrolase 1 deficiency.
Topics: Adult; Age of Onset; Aged; Antiparkinson Agents; Child; Codon, Nonsense; Depressive Disorder; Dystonia; Exercise; Exons; Family; Female; GTP Cyclohydrolase; Humans; Levodopa; Male; Parkinsonian Disorders; Pedigree; Restless Legs Syndrome | 2010 |
Four novel mutations in the GCH1 gene of Chinese patients with dopa-responsive dystonia.
Topics: Adult; Asian People; Dopamine Agents; Dystonia; Female; Gene Frequency; Genotype; GTP Cyclohydrolase; Humans; Levodopa; Mutation; Retrospective Studies; Sequence Analysis, DNA; Young Adult | 2010 |
Movement disorders ii: chorea, dystonia, myoclonus, and tremor.
Topics: Child; Chorea; Dopamine Agents; Dyskinesia, Drug-Induced; Dyskinesias; Dystonia; Humans; Levodopa; Lupus Erythematosus, Systemic; Myoclonus; Tremor | 2010 |
Greeter's cramp.
Topics: Dystonia; Female; Humans; Levodopa; Middle Aged; Mouth; Mouth Diseases; Treatment Outcome; Video Recording | 2010 |
Effect of low-frequency repetitive transcranial magnetic stimulation combined with physical therapy on L-dopa-induced painful off-period dystonia in Parkinson's disease.
Topics: Antiparkinson Agents; Dystonia; Evoked Potentials, Motor; Humans; Levodopa; Male; Middle Aged; Pain Measurement; Parkinson Disease; Transcranial Magnetic Stimulation | 2011 |
Dyskinesias do not develop after chronic intermittent levodopa therapy in clinically hemiparkinsonian rhesus monkeys.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Antiparkinson Agents; Behavior, Animal; Carotid Arteries; Conditioning, Operant; Corpus Striatum; Dihydroxyphenylalanine; Dopamine Agents; Dyskinesia, Drug-Induced; Dystonia; Female; Injections, Intravenous; Levodopa; Macaca mulatta; MPTP Poisoning; Parkinson Disease, Secondary; Psychomotor Performance; Radionuclide Imaging; Radiopharmaceuticals; Substantia Nigra | 2011 |
Behavioural and pharmacological examinations in a transgenic mouse model of early-onset torsion dystonia.
Topics: Amphetamines; Animals; Anxiety; Behavior, Animal; Carbidopa; Chromans; Disease Models, Animal; Dystonia; Levodopa; Locomotion; Mice; Mice, Transgenic; Quinpirole; Raclopride | 2011 |
An intragenic duplication in guanosine triphosphate cyclohydrolase-1 gene in a dopa-responsive dystonia family.
Topics: Adult; Antiparkinson Agents; Dystonia; Family Health; Female; Genes, Duplicate; Genetic Testing; GTP Cyclohydrolase; Humans; Levodopa; Male; Young Adult | 2011 |
[Levodopa-responsive parkinsonism-dystonia due to a traumatic injury of the substantia nigra].
Topics: Antiparkinson Agents; Brain; Brain Injuries; Dystonia; Humans; Levodopa; Magnetic Resonance Imaging; Male; Middle Aged; Parkinsonian Disorders; Substantia Nigra; Tomography, X-Ray Computed | 2012 |
Successful subthalamic stimulation in genetic Parkinson's disease caused by duplication of the α-synuclein gene.
Topics: Adult; alpha-Synuclein; Antiparkinson Agents; Deep Brain Stimulation; Depressive Disorder; Dystonia; Executive Function; Female; Follow-Up Studies; Functional Laterality; Gene Duplication; Humans; Levodopa; Neuropsychological Tests; Neurosurgical Procedures; Parkinson Disease; Subthalamic Nucleus; Treatment Outcome | 2012 |
Occurrence of GCH1 gene mutations in a group of Indian dystonia patients.
Topics: Adult; Asian People; DNA Mutational Analysis; Dopamine Agents; Dystonia; Family Health; Female; Genetic Predisposition to Disease; GTP Cyclohydrolase; Humans; India; Levodopa; Male; Middle Aged; Mutation; Parkinson Disease | 2012 |
Successful subthalamic stimulation, but levodopa-induced dystonia, in a genetic Parkinson's disease.
Topics: Antiparkinson Agents; Deep Brain Stimulation; Dystonia; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Subthalamic Nucleus | 2013 |
The effect of piribedil on L-DOPA-induced dyskinesias in a rat model of Parkinson's disease: differential role of α(2) adrenergic mechanisms.
Topics: Adrenergic Agents; Adrenergic alpha-2 Receptor Agonists; Adrenergic alpha-2 Receptor Antagonists; Animals; Antiparkinson Agents; Benserazide; Clonidine; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Administration Schedule; Dyskinesia, Drug-Induced; Dystonia; Facial Asymmetry; Idazoxan; Levodopa; Locomotion; Oxidopamine; Parkinson Disease; Piribedil; Rats; Rats, Sprague-Dawley; Receptors, Adrenergic, alpha-2; Statistics, Nonparametric; Upper Extremity | 2013 |
Neuroleptic malignant syndrome associated with the use of carbidopa/levodopa for dystonia in persons with cerebral palsy.
Topics: Carbidopa; Cerebral Palsy; Child; Dopamine Agents; Drug Therapy, Combination; Dystonia; Follow-Up Studies; Humans; Levodopa; Male; Neuroleptic Malignant Syndrome | 2012 |
[Clinical and therapeutic aspects in Tunisian patients with dystonia: a 5-year prospective study].
Topics: Adolescent; Adult; Age of Onset; Anti-Dyskinesia Agents; Antiparkinson Agents; Botulinum Toxins; Child; Consanguinity; Dystonia; Female; Heredodegenerative Disorders, Nervous System; Hospitalization; Humans; Levodopa; Male; Middle Aged; Prospective Studies; Tunisia | 2013 |
[Diagnosis of dopa-responsive dystonia after 34 years: complete remission after L-dopa treatment].
Topics: Adult; Delayed Diagnosis; Dystonia; Female; Humans; Levodopa; Remission Induction; Treatment Outcome | 2012 |
Foot dystonia heralding levodopa-induced dyskinesias in Parkinson disease.
Topics: Antiparkinson Agents; Carbidopa; Catechols; Dyskinesia, Drug-Induced; Dystonia; Female; Foot Diseases; Humans; Levodopa; Middle Aged; Neurologic Examination; Nitriles; Parkinson Disease | 2013 |
DYT16: the original cases.
Topics: Adolescent; Adult; Age of Onset; Anti-Dyskinesia Agents; Antiparkinson Agents; Baclofen; Biperiden; Botulinum Toxins; Carbidopa; Child; Child, Preschool; Cholinergic Antagonists; Drug Combinations; Drug Resistance; Dystonia; Dystonic Disorders; Female; Humans; Levodopa; Male; Middle Aged; Muscle Relaxants, Central; Mutation; Parkinsonian Disorders; Pedigree; Phenotype; RNA-Binding Proteins; Speech Disorders; Trihexyphenidyl; Young Adult | 2012 |
Guanosine triphosphate cyclohydrolase 1 promoter deletion causes dopa-responsive dystonia.
Topics: Adult; Belgium; Chromosome Mapping; Dopamine Agents; Dystonia; Family Health; Female; Genetic Linkage; Genome-Wide Association Study; GTP Cyclohydrolase; Humans; Levodopa; Male; Middle Aged; Promoter Regions, Genetic; Sequence Deletion; Young Adult | 2012 |
Pitfalls in phenylalanine loading test in the diagnosis of dopa-responsive dystonia.
Topics: Administration, Oral; Adult; Biopterins; Diagnosis, Differential; Dystonia; Dystonic Disorders; Female; Humans; Levodopa; Metabolism, Inborn Errors; Phenylalanine; Phenylalanine Hydroxylase; Phenylketonurias; Psychomotor Disorders; Tyrosine | 2013 |
Brain biopterin and tyrosine hydroxylase in asymptomatic dopa-responsive dystonia.
Topics: Antiparkinson Agents; Biopterins; Brain; Dystonia; Fatal Outcome; Female; Humans; Levodopa; Middle Aged; Syndrome; Tyrosine 3-Monooxygenase | 2002 |
Neuroleptic malignant syndrome with prolonged catatonia in a dopa-responsive dystonia patient.
Topics: Adult; Catatonia; Dystonia; Electroencephalography; Female; GTP Cyclohydrolase; Humans; Levodopa; Neuroleptic Malignant Syndrome | 2002 |
Autosomal dominant GTP-CH deficiency presenting as a dopa-responsive myoclonus-dystonia syndrome.
Topics: Adolescent; Adult; Diagnosis, Differential; Dystonia; Female; Genes, Dominant; Genetic Carrier Screening; GTP Cyclohydrolase; Humans; Levodopa; Male; Middle Aged; Mutation, Missense; Myoclonus; Pedigree; Syndrome | 2002 |
Dystonia is predictive of subsequent altered dopaminergic responsiveness in a chronic 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine+3-nitropropionic acid model of striatonigral degeneration in monkeys.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Antiparkinson Agents; Corpus Striatum; Disease Models, Animal; Dopamine; Dopamine Agents; Dystonia; Female; Levodopa; Macaca fascicularis; Neurotoxins; Nitro Compounds; Parkinsonian Disorders; Propionates; Putamen; Striatonigral Degeneration; Substantia Nigra | 2002 |
Frequency of apraxia of eyelid opening in the general population and in patients with extrapyramidal disorders.
Topics: Adult; Age of Onset; Aged; Antiparkinson Agents; Apomorphine; Apraxias; Blepharospasm; Dystonia; Eyelids; Female; Humans; Italy; Levodopa; Male; Middle Aged; Parkinsonian Disorders; Supranuclear Palsy, Progressive | 2002 |
Neonatal dopa-responsive extrapyramidal syndrome in twins with recessive GTPCH deficiency.
Topics: Adolescent; Antiparkinson Agents; Basal Ganglia Diseases; Carbidopa; Dopamine Agents; Dystonia; Female; Follow-Up Studies; Genes, Recessive; GTP Cyclohydrolase; Homozygote; Humans; Infant, Newborn; Infant, Newborn, Diseases; Levodopa; Metabolism, Inborn Errors; Muscle Rigidity; Mutation; Reflex, Abnormal; Remission Induction; Treatment Outcome; Tremor | 2003 |
Levodopa-induced oromandibular dystonia in progressive supranuclear palsy.
Topics: Aged; Antiparkinson Agents; Dystonia; Humans; Levodopa; Male; Mandible; Mouth; Supranuclear Palsy, Progressive | 2003 |
Dopa-responsive dystonia and Tourette syndrome in a large Danish family.
Topics: Adult; Aged; Denmark; DNA Mutational Analysis; Dopamine Agents; Dystonia; Female; Humans; Levodopa; Male; Middle Aged; Mutation; Pedigree; Tourette Syndrome | 2003 |
Parkin disease: a phenotypic study of a large case series.
Topics: Adult; Age of Onset; Aged; Aged, 80 and over; Autonomic Nervous System Diseases; Dystonia; Female; Genetic Predisposition to Disease; Humans; Levodopa; Ligases; Male; Mental Disorders; Middle Aged; Mutation; Parkinsonian Disorders; Pedigree; Phenotype; Polymerase Chain Reaction; Ubiquitin-Protein Ligases | 2003 |
Spinocerebellar ataxia type 3 presenting as an L-DOPA responsive dystonia phenotype in a Chinese family.
Topics: Adult; Asian People; Blotting, Southern; DNA Mutational Analysis; Dystonia; Family Health; Female; Humans; Levodopa; Machado-Joseph Disease; Magnetic Resonance Imaging; Mutation; Phenotype | 2003 |
Tyrosine hydroxylase deficiency causes progressive encephalopathy and dopa-nonresponsive dystonia.
Topics: Amino Acid Metabolism, Inborn Errors; Biogenic Monoamines; Brain Diseases, Metabolic; Child; Child, Preschool; Chromatography, High Pressure Liquid; Dopamine Agents; Dystonia; Female; Humans; Infant; Levodopa; Male; Mutation; Neurotransmitter Agents; Polymorphism, Genetic; Terminology as Topic; Tyrosine 3-Monooxygenase | 2003 |
A case report of dopa-responsive dystonia.
Topics: Adolescent; Antiparkinson Agents; Benserazide; Drug Combinations; Dystonia; Humans; Levodopa; Male | 2001 |
[A patient with multiple system atrophy presenting prolonged levodopa-responsive parkinsonism and off-dystonia of the trunk].
Topics: Brain; Diagnosis, Differential; Dystonia; Humans; Levodopa; Magnetic Resonance Imaging; Male; Middle Aged; Multiple System Atrophy; Olivopontocerebellar Atrophies; Parkinsonian Disorders; Time Factors | 2003 |
Is phenotypic variation of hereditary progressive dystonia with marked diurnal fluctuation/dopa-responsive dystonia (HPD/DRD) caused by the difference of the locus of mutation on the GTP cyclohydrolase 1 (GCH-1) gene?
Topics: Adolescent; Adult; Age of Onset; Aged; Aged, 80 and over; DNA Mutational Analysis; Dystonia; Exons; Family Health; Female; GTP Cyclohydrolase; Humans; Introns; Levodopa; Male; Middle Aged; Mutation; Pedigree; Phenotype | 2004 |
Patient with limb girdle dystrophy presenting with dopa-responsive dystonia--a case report.
Topics: Adolescent; Dopamine Agents; Drug Therapy, Combination; Dystonia; Humans; Levodopa; Male; Muscular Dystrophies; Treatment Outcome; Trihexyphenidyl | 2003 |
Clinical and [99mTc]TRODAT-1/[123I]IBZM SPECT imaging findings in dopa-responsive dystonia.
Topics: Adult; Benzamides; Brain; Contrast Media; Diagnosis, Differential; Dopamine Agents; Dopamine Plasma Membrane Transport Proteins; Dystonia; Female; Humans; Levodopa; Membrane Glycoproteins; Membrane Transport Proteins; Nerve Tissue Proteins; Organotechnetium Compounds; Parkinsonian Disorders; Pyrrolidines; Radiopharmaceuticals; Receptors, Dopamine D2; Tomography, Emission-Computed, Single-Photon; Tropanes | 2004 |
Dopa-responsive dystonia due to mild tyrosine hydroxylase deficiency.
Topics: Amino Acid Metabolism, Inborn Errors; Brain Diseases, Metabolic; Dystonia; GTP Cyclohydrolase; Humans; Levodopa; Male; Mutation; Phenotype; Tyrosine 3-Monooxygenase | 2004 |
Striatal dopaminergic system in dopa-responsive dystonia: a multi-tracer PET study shows increased D2 receptors.
Topics: Adolescent; Adult; Aged; Child; Corpus Striatum; Dopamine; Dystonia; Female; Humans; Levodopa; Male; Middle Aged; Receptors, Dopamine D2; Tomography, Emission-Computed | 2004 |
Presynaptic mechanisms of motor fluctuations in Parkinson's disease: a probabilistic model.
Topics: Antiparkinson Agents; Biological Clocks; Circadian Rhythm; Dopamine; Dopamine Agents; Dyskinesia, Drug-Induced; Dystonia; Humans; Levodopa; Models, Statistical; Parkinson Disease; Presynaptic Terminals; Synaptic Vesicles | 2004 |
Alternating hemiplegia of childhood: presentation of two cases regarding the extent of variability.
Topics: Anticonvulsants; Cerebral Cortex; Child; Diagnosis, Differential; Disease Progression; Dose-Response Relationship, Drug; Drug Tolerance; Dystonia; Electroencephalography; Epilepsy, Partial, Motor; Epilepsy, Reflex; Female; Hemiplegia; Humans; Infant; Levodopa; Neurologic Examination; Status Epilepticus; Sudden Infant Death | 2004 |
[Dopa-responsive dystonia (Segawa variant): clinical analysis of 7 cases with delayed diagnosis].
Topics: Adolescent; Adult; Child; Diagnosis, Differential; Dopamine Agonists; Dose-Response Relationship, Drug; Dystonia; Female; Humans; Levodopa; Male | 2003 |
Arg(184)His mutant GTP cyclohydrolase I, causing recessive hyperphenylalaninemia, is responsible for dopa-responsive dystonia with parkinsonism: a case report.
Topics: Antiparkinson Agents; Arginine; Brain; Dystonia; Genes, Recessive; GTP Cyclohydrolase; Humans; Levodopa; Magnetic Resonance Imaging; Male; Middle Aged; Parkinsonian Disorders; Pedigree; Phenylketonurias; Point Mutation; Tomography, Emission-Computed; Tomography, Emission-Computed, Single-Photon | 2004 |
Molecular chaperones affect GTP cyclohydrolase I mutations in dopa-responsive dystonia.
Topics: Animals; Animals, Newborn; Benzoquinones; Blotting, Northern; Blotting, Western; Cell Line; Cricetinae; DNA Mutational Analysis; Dystonia; Embryo, Mammalian; Enzyme Inhibitors; Gene Expression Regulation; Glutamic Acid; Glycine; GTP Cyclohydrolase; Heat-Shock Proteins; HSP40 Heat-Shock Proteins; HSP70 Heat-Shock Proteins; HSP90 Heat-Shock Proteins; Humans; Lactams, Macrocyclic; Levodopa; Molecular Chaperones; Mutation; Proteins; Quinones; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Time Factors; Transfection | 2004 |
Wide expressivity variation and high but no gender-related penetrance in two dopa-responsive dystonia families with a novel GCH-I mutation.
Topics: Adult; DNA Mutational Analysis; DNA, Single-Stranded; Dopamine Agonists; Dystonia; Female; Gene Expression; Genetic Variation; GTP Cyclohydrolase; Haplotypes; Humans; Levodopa; Male; Middle Aged; Pedigree; Phenotype; Point Mutation; Polymorphism, Genetic | 2004 |
Long-term course of L-dopa-responsive dystonia caused by tyrosine hydroxylase deficiency.
Topics: Adult; Age of Onset; Brain; Brain Chemistry; Catecholamines; Disease Progression; DNA Mutational Analysis; Dopamine Agents; Dystonia; Heterozygote; Humans; Levodopa; Longitudinal Studies; Magnetic Resonance Imaging; Male; Middle Aged; Panic Disorder; Point Mutation; Siblings; Time; Tyrosine 3-Monooxygenase | 2004 |
Effect of levodopa treatment for parkinsonism in welders: a double-blind study.
Topics: Age of Onset; Brain; Clinical Trials as Topic; Diagnosis, Differential; Diagnostic Errors; Dopamine Agents; Double-Blind Method; Dystonia; Gait Disorders, Neurologic; Humans; Levodopa; Manganese; Manganese Poisoning; Occupational Exposure; Parkinson Disease, Secondary; Tremor; Welding | 2004 |
The metabolic pathology of dopa-responsive dystonia.
Topics: Adult; Brain; Brain Mapping; Dystonia; Female; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Levodopa; Male; Parkinson Disease; Positron-Emission Tomography | 2005 |
Stimulation of the globus pallidus internus for childhood-onset dystonia.
Topics: Adolescent; Adult; Age of Onset; Antiparkinson Agents; Child; Child, Preschool; Deep Brain Stimulation; Dystonia; Female; Globus Pallidus; Humans; Infant; Levodopa; Male; Surveys and Questionnaires; Videotape Recording; Walking | 2005 |
Treatment of progressive supranuclear palsy and corticobasal degeneration.
Topics: Amantadine; Cerebral Cortex; Cholinesterase Inhibitors; Corpus Striatum; Donepezil; Dopamine Agents; Dopamine Agonists; Dystonia; Globus Pallidus; Humans; Indans; Levodopa; Nerve Degeneration; Piperidines; Substantia Nigra; Supranuclear Palsy, Progressive | 2005 |
Long-term follow-up and adult outcome of 6-pyruvoyl-tetrahydropterin synthase deficiency.
Topics: Adolescent; Adult; Antiparkinson Agents; Athetosis; Child; Child, Preschool; Chorea; Dose-Response Relationship, Drug; Dystonia; Female; Follow-Up Studies; Humans; Infant; Infant, Newborn; Levodopa; Long-Term Care; Muscle Hypotonia; Neurologic Examination; Phenylketonurias; Phosphorus-Oxygen Lyases; Pterins; Treatment Outcome | 2006 |
Dopa-responsive dystonia and early-onset Parkinson's disease in a patient with GTP cyclohydrolase I deficiency?
Topics: Adult; Alzheimer Disease; Antiparkinson Agents; DNA Mutational Analysis; Dystonia; Family Health; GTP Cyclohydrolase; Humans; Iodine Isotopes; Levodopa; Male; Mutation; Tomography, Emission-Computed, Single-Photon; Tropanes | 2006 |
Abnormal circuit function in dystonia.
Topics: Brain; Dihydroxyphenylalanine; Dystonia; Humans; Levodopa; Spinal Cord | 2006 |
[A 62-year-old woman with early-onset Parkinson's disease associated with the PINKi gene deletion].
Topics: Age Factors; Antiparkinson Agents; Dementia; Dystonia; Female; Gene Deletion; Humans; Levodopa; Middle Aged; Mutation; Parkinson Disease; Protein Kinases | 2006 |
Effective treatment with levodopa and carbidopa for hypomyelination with atrophy of the basal ganglia and cerebellum.
Topics: Administration, Oral; Antiparkinson Agents; Atrophy; Basal Ganglia; Carbidopa; Cerebellum; Child, Preschool; Demyelinating Diseases; Diagnosis, Differential; Drug Therapy, Combination; Dystonia; Fluorodeoxyglucose F18; Humans; Levodopa; Magnetic Resonance Imaging; Male; Positron-Emission Tomography; Spinocerebellar Degenerations; Treatment Outcome | 2006 |
Is there a role for physiotherapy during deep brain stimulation surgery in patients with Parkinson's disease?
Topics: Antiparkinson Agents; Deep Brain Stimulation; Dystonia; Female; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Physical Therapy Modalities; Retrospective Studies; Treatment Outcome | 2006 |
Dopa-responsive dystonic camptocormia.
Topics: Dopamine Agents; Dystonia; Gait Disorders, Neurologic; Humans; Levodopa; Male; Middle Aged; Treatment Outcome | 2006 |
Levodopa can worsen tremor associated with dystonia.
Topics: Aged; Antiparkinson Agents; Carbidopa; Diagnostic Errors; Drug Combinations; Dystonia; Female; Humans; Levodopa; Neurologic Examination; Parkinsonian Disorders; Psychomotor Performance; Tremor | 2006 |
Case records of the Massachusetts General Hospital. Case 26-2006. A 19-year-old woman with difficulty walking.
Topics: Adult; Diagnosis, Differential; Dystonia; Dystonic Disorders; Female; Gait Disorders, Neurologic; GTP Cyclohydrolase; Humans; Levodopa; Movement Disorders | 2006 |
[Clinical analysis of dopa-responsive dystonia and mutation analysis of the GCH I gene].
Topics: Age of Onset; Child; China; DNA Mutational Analysis; Dopamine Agents; Dystonia; Early Diagnosis; Female; Genotype; GTP Cyclohydrolase; Humans; Levodopa; Male; Molecular Sequence Data; Mutation; Mutation, Missense; Pedigree; Phenotype; Polymerase Chain Reaction; Sex Factors; Treatment Outcome | 2006 |
Cerebral folate deficiency and folinic acid treatment in hypomyelination with atrophy of the basal ganglia and cerebellum (H-ABC) syndrome.
Topics: Antiparkinson Agents; Atrophy; Basal Ganglia; Brain Diseases, Metabolic; Carbidopa; Cerebellum; Demyelinating Diseases; Dystonia; Female; Folic Acid Deficiency; Humans; Leucovorin; Levodopa; Male; Syndrome; Tetrahydrofolates; Treatment Outcome; Vitamin B Complex | 2007 |
Myoclonus-dystonia syndrome with severe depression is caused by an exon-skipping mutation in the epsilon-sarcoglycan gene.
Topics: Adult; Aged; Antiparkinson Agents; Depressive Disorder, Major; Drug Administration Schedule; Dystonia; Exons; Gene Expression; Humans; Incidence; Levodopa; Male; Myoclonus; Point Mutation; Sarcoglycans | 2007 |
Congenital DOPA-responsive disorders: a diagnostic and therapeutic challenge to the cerebral palsies?
Topics: Cerebral Palsy; Diagnosis, Differential; Diagnostic Errors; Dopamine Agents; Dystonia; Humans; Levodopa | 2007 |
Dopa-responsive dystonia (Segawa disease) -like disease accompanied by mental retardation: a case report.
Topics: Adult; Antiparkinson Agents; Brain; Drug Administration Schedule; Dystonia; Female; Humans; Intellectual Disability; Levodopa; Magnetic Resonance Imaging; Neopterin; Treatment Outcome; Wechsler Scales | 2007 |
Adult-onset dystonia: atypical manifestation of Segawa disease.
Topics: Adult; Dopamine Agents; Dystonia; Electromyography; Female; Humans; Levodopa; Magnetic Resonance Imaging | 2007 |
Neurodegeneration with brain iron accumulation: clinical, radiographic and genetic heterogeneity and corresponding therapeutic options.
Topics: Adolescent; Brain; Brain Diseases, Metabolic; Diagnosis, Differential; DNA Mutational Analysis; Dystonia; Female; Genetic Predisposition to Disease; Humans; Iron; Iron Metabolism Disorders; Levodopa; Magnetic Resonance Imaging; Male; Middle Aged; Mutation; Neurodegenerative Diseases; Pantothenate Kinase-Associated Neurodegeneration; Phosphotransferases (Alcohol Group Acceptor); Treatment Outcome | 2007 |
Study of a Swiss dopa-responsive dystonia family with a deletion in GCH1: redefining DYT14 as DYT5.
Topics: Adult; Aged; Amino Acid Sequence; Dystonia; Female; Genetic Linkage; GTP Cyclohydrolase; Humans; Levodopa; Male; Middle Aged; Molecular Sequence Data; Pedigree; Quantitative Trait Loci; Sequence Deletion; Switzerland | 2008 |
A case of levodopa-responsive camptocormia associated with advanced Parkinson's disease.
Topics: Diagnosis, Differential; Dystonia; Gait Disorders, Neurologic; Humans; Levodopa; Male; Middle Aged; Parkinson Disease | 2007 |
Novel GCH1 mutation in a Brazilian family with dopa-responsive dystonia.
Topics: Arginine; Brazil; Dopamine Agents; Dystonia; Family Health; GTP Cyclohydrolase; Humans; Levodopa; Lysine; Methionine; Mutation; Valine | 2008 |
[Segawa disease].
Topics: Aging; Brain; Dopamine; Dystonia; Female; GTP Cyclohydrolase; History, 20th Century; Humans; Levodopa; Phenotype; Pteridines | 2008 |
Stuart Green's vignettes 1 and 2.
Topics: Adolescent; Antiparkinson Agents; Ataxia; Cerebral Palsy; Child; Dystonia; Female; Humans; Levodopa; Male; Ocular Motility Disorders | 2008 |
A novel missense mutation pattern of the GCH1 gene in dopa-responsive dystonia.
Topics: Child; Dopamine Agents; Dystonia; Female; GTP Cyclohydrolase; Heterozygote; Humans; Levodopa; Mutation, Missense; Phenylalanine; Tyrosine | 2007 |
Problems of levodopa treatment.
Topics: Corpus Striatum; Dopamine; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Dyskinesia, Drug-Induced; Dystonia; Humans; Levodopa; Long-Term Care; Parkinson Disease; Receptors, Dopamine; Substantia Nigra | 1984 |
Bromocriptine in treatment of levodopa-induced end-of-dose dystonia.
Topics: Bromocriptine; Dystonia; Female; Humans; Levodopa; Middle Aged; Parkinson Disease | 1980 |
Bromocriptine for levodopa-induced end-of-dose dystonia.
Topics: Aged; Bromocriptine; Dystonia; Female; Humans; Levodopa; Parkinson Disease | 1981 |
Spasmodic torticollis and other idiopathic torsion dystonias. Medical management.
Topics: Adrenergic Agents; Amantadine; Antipsychotic Agents; Apomorphine; Benzodiazepines; Carbamazepine; Dystonia; Humans; Levodopa; Parasympatholytics; Torsion Abnormality; Torticollis | 1984 |
Treatment of non-fluctuating progressive dystonia: a neuropharmacological approach.
Topics: Adolescent; Basal Ganglia; Child; Chromatography, High Pressure Liquid; Dystonia; Female; Homovanillic Acid; Humans; Hydroxyindoleacetic Acid; Levodopa; Male; Phenylacetates; Synaptic Transmission; Syndrome | 1984 |
Treatment of dyskinetic and dystonic disorders with CF 25-397: clinical and pharmacological aspects.
Topics: Aged; Carbidopa; Dystonia; Ergolines; Female; Hepatolenticular Degeneration; Humans; Huntington Disease; Levodopa; Male; Middle Aged; Movement Disorders; Parkinson Disease | 1980 |
[Early morning dystonia: a complication of levodopa therapy in Parkinson disease. Presentation of 4 cases].
Topics: Dystonia; Female; Foot; Humans; Levodopa; Middle Aged; Parkinson Disease; Time Factors | 1984 |
Clonidine therapy for tardive dyskinesia and related syndromes.
Topics: Adult; Aged; Clonidine; Dyskinesia, Drug-Induced; Dystonia; Female; Humans; Levodopa; Male; Middle Aged; Movement Disorders | 1984 |
Progressive dystonia with marked diurnal fluctuation in a Chinese family.
Topics: Adolescent; Child; Circadian Rhythm; Dystonia; Female; Humans; Levodopa; Male | 1984 |
[5 cases of dystonia with marked diurnal fluctuation and special reference to homovanillic acid in CSF].
Topics: Adolescent; Adult; Brain; Circadian Rhythm; Dopamine; Dystonia; Female; Humans; Hydroxybenzoates; Levodopa; Male; Vanillic Acid | 1984 |
Dystonia--L-dopa responsive or juvenile parkinsonism?
Topics: Adolescent; Benserazide; Carbidopa; Child; Child, Preschool; Dose-Response Relationship, Drug; Drug Therapy, Combination; Dystonia; Follow-Up Studies; Growth Hormone; Humans; Infant; Levodopa; Male; Parkinson Disease; Prolactin | 1983 |
Neuropharmacological profile of Meige's disease: overview and a case report.
Topics: Aged; Baclofen; Benztropine; Clonazepam; Doxepin; Drug Therapy, Combination; Dystonia; Facial Muscles; Haloperidol; Humans; Levodopa; Male; Spasm | 1983 |
Meige's syndrome during long-term dopaminergic therapy in Parkinson's disease.
Topics: Aged; Blepharospasm; Carbidopa; Dystonia; Facial Muscles; Female; Humans; Levodopa; Male; Mandibular Diseases; Middle Aged; Parkinson Disease; Syndrome; Time Factors | 1982 |
Fluctuating dystonia and allied syndromes.
Topics: Child; Diagnosis, Differential; Dystonia; Dystonia Musculorum Deformans; Female; Humans; Levodopa; Male | 1982 |
Iris pigmentation (melanin) in idiopathic dystonic syndromes including torticollis.
Topics: Adolescent; Adult; Aged; Child; Child, Preschool; Dyskinesia, Drug-Induced; Dystonia; Eye Color; Humans; Levodopa; Melanins; Middle Aged; Torsion Abnormality; Torticollis; White People | 1981 |
Dystonic foot response of Parkinsonism.
Topics: Aged; Carbidopa; Dystonia; Foot Diseases; Humans; Levodopa; Parkinson Disease; Receptors, Dopamine | 1980 |
Electroconvulsive therapy in Parkinsonian patients with the "on-off" syndrome.
Topics: Depression; Dyskinesia, Drug-Induced; Dystonia; Electroconvulsive Therapy; Female; Humans; Levodopa; Male; Middle Aged; Parkinson Disease | 1980 |
DOPA-sensitive progressive dystonia of childhood with diurnal fluctuations of symptoms: a case report.
Topics: Age Factors; Child; Dopamine Agents; Dystonia; Female; Humans; Levodopa; Periodicity; Posture; Syndrome | 1995 |
Dopa responsive dystonia.
Topics: Child; Circadian Rhythm; Diagnostic Errors; Dystonia; Female; Gait; Humans; Levodopa; Male; Medical History Taking | 1995 |
[Dopa-responsive dystonia].
Topics: Adult; Child; Diagnosis, Differential; Dystonia; Dystonia Musculorum Deformans; Female; Humans; Levodopa; Prognosis | 1994 |
Exon skipping caused by a base substitution at a splice site in the GTP cyclohydrolase I gene in a Japanese family with hereditary progressive dystonia dopa responsive dystonia.
Topics: Adult; Base Sequence; Dystonia; Exons; Frameshift Mutation; GTP Cyclohydrolase; Humans; Japan; Levodopa; Male; Molecular Sequence Data; Mutation; Polymerase Chain Reaction; RNA Splicing; RNA-Directed DNA Polymerase; RNA, Messenger | 1995 |
A family with hereditary juvenile dystonia-parkinsonism.
Topics: Adult; Aged; Antiparkinson Agents; Chromosome Aberrations; Chromosome Disorders; Dystonia; Female; Follow-Up Studies; Genes, Dominant; Homovanillic Acid; Humans; Levodopa; Male; Middle Aged; Neurologic Examination; Parkinson Disease; Pedigree; Torticollis | 1995 |
Delayed onset generalised dystonia after cyanide poisoning.
Topics: Adult; Carbidopa; Drug Overdose; Drug Therapy, Combination; Dystonia; Female; Follow-Up Studies; Humans; Levodopa; Magnetic Resonance Imaging; Neurologic Examination; Potassium Cyanide; Putamen; Suicide, Attempted | 1995 |
Correction of foot deformity by the Ilizarov method in a patient with Segawa disease.
Topics: Adult; Ankle Joint; Clubfoot; Dystonia; External Fixators; Female; Humans; Levodopa; Range of Motion, Articular | 1995 |
GTP cyclohydrolase I activity in mononuclear blood cells in juvenile parkinsonism.
Topics: Basal Ganglia; Dystonia; GTP Cyclohydrolase; Humans; Levodopa; Lymphocytes; Monocytes; Parkinson Disease | 1995 |
"Off" painful dystonia in Parkinson's disease treated with botulinum toxin.
Topics: Aged; Botulinum Toxins; Dystonia; Electromyography; Female; Foot; Humans; Injections, Intramuscular; Levodopa; Male; Middle Aged; Muscle Contraction; Neurologic Examination; Pain; Parkinson Disease; Walking | 1995 |
Thalamotomy for the alleviation of levodopa-induced dyskinesia: experimental studies in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-treated parkinsonian monkey.
Topics: Afferent Pathways; Animals; Apomorphine; Axonal Transport; Brain Mapping; Chorea; Dyskinesia, Drug-Induced; Dystonia; Globus Pallidus; Horseradish Peroxidase; Levodopa; Macaca fascicularis; MPTP Poisoning; Parkinson Disease, Secondary; Stereotaxic Techniques; Thalamus; Wheat Germ Agglutinins | 1993 |
The gene for hereditary progressive dystonia with marked diurnal fluctuation maps to chromosome 14q.
Topics: Chromosome Mapping; Chromosomes, Human, Pair 14; Circadian Rhythm; Dystonia; Female; Genetic Linkage; Genotype; Humans; Levodopa; Lod Score; Male; Pedigree; Polymerase Chain Reaction | 1995 |
Remission in dihydroxyphenylalanine-responsive dystonia.
Topics: Child; Dihydroxyphenylalanine; Dystonia; Humans; Levodopa; Male; Movement Disorders; Treatment Outcome | 1995 |
An early onset of hereditary progressive dystonia with marked diurnal fluctuation: determining clinical status using gait analysis.
Topics: Age of Onset; Child, Preschool; Circadian Rhythm; Dystonia; Electromyography; Female; Gait; Humans; Levodopa | 1995 |
MRI and PET studies of manganese-intoxicated monkeys.
Topics: Animals; Carbidopa; Corpus Striatum; Deoxyglucose; Drug Therapy, Combination; Dystonia; Fluorodeoxyglucose F18; Globus Pallidus; Glucose; Levodopa; Macaca mulatta; Magnetic Resonance Imaging; Male; Manganese Poisoning; Parkinson Disease, Secondary; Raclopride; Salicylamides; Substantia Nigra; Tomography, Emission-Computed | 1995 |
A clue to the pathogenesis of dopa-responsive dystonia.
Topics: Biopterins; Chromosome Aberrations; Chromosome Disorders; Corpus Striatum; Dopamine; Dystonia; Humans; Levodopa; Neopterin; Tyrosine 3-Monooxygenase | 1995 |
Successful treatment of hereditary progressive dystonia--a case report.
Topics: Adult; Dystonia; Female; Foot Deformities, Acquired; Humans; Levodopa; Orthotic Devices; Radiography | 1994 |
Dopa-responsive dystonia and normalization of soleus H-reflex test results with treatment.
Topics: Adult; Carbidopa; Drug Combinations; Dystonia; Female; H-Reflex; Humans; Levodopa; Male; Middle Aged; Muscle, Skeletal | 1995 |
Hereditary progressive dystonia with marked diurnal fluctuation caused by mutations in the GTP cyclohydrolase I gene.
Topics: Age of Onset; Biopterins; Brain; Chromosome Mapping; Chromosomes, Human, Pair 14; Circadian Rhythm; Cloning, Molecular; DNA Mutational Analysis; Dopamine; Dystonia; Escherichia coli; Female; GTP Cyclohydrolase; Heterozygote; Humans; Hybrid Cells; Levodopa; Male; Mutagenesis, Site-Directed; Mutation; Nerve Tissue Proteins; Pedigree; Polymerase Chain Reaction; Sequence Alignment; Sequence Homology, Amino Acid; Species Specificity; Tyrosine 3-Monooxygenase | 1994 |
Dopa-responsive dystonia simulating cerebral palsy.
Topics: Adolescent; Adult; Biopterins; Carbidopa; Cerebral Palsy; Child; Diagnosis, Differential; Dose-Response Relationship, Drug; Drug Administration Schedule; Dystonia; Female; Follow-Up Studies; Homovanillic Acid; Humans; Levodopa; Male; Neopterin; Neurologic Examination; Parkinson Disease, Secondary | 1994 |
[Progressive hereditary dystonia with diurnal fluctuations: report of 2 cases].
Topics: Adult; Age Factors; Circadian Rhythm; Dystonia; Family Health; Female; Humans; Levodopa; Male; Tyrosine 3-Monooxygenase | 1993 |
Dopa-responsive dystonia: pathological and biochemical observations in a case.
Topics: Adult; Brain; Child; Dopamine; Dystonia; Female; Homovanillic Acid; Humans; Levodopa; Radioligand Assay; Tyrosine 3-Monooxygenase | 1994 |
What is dystonia?
Topics: Dystonia; Humans; Levodopa | 1994 |
[A family of parkinsonism in which the clinical feature of constituents varied with the age of onset].
Topics: Age of Onset; Circadian Rhythm; Dystonia; Female; Gait; Humans; Levodopa; Middle Aged; Parkinson Disease; Pedigree | 1994 |
Dopa-responsive dystonia.
Topics: Dystonia; Humans; Levodopa | 1994 |
Adductor laryngeal breathing dystonia in a patient with lubag (X-linked dystonia-Parkinsonism syndrome).
Topics: Airway Obstruction; Antiparkinson Agents; Botulinum Toxins; Carbidopa; Dose-Response Relationship, Drug; Drug Therapy, Combination; Dystonia; Electromyography; Genes, Recessive; Humans; Injections, Intramuscular; Laryngeal Diseases; Levodopa; Male; Middle Aged; Parkinson Disease; Respiration Disorders; Respiratory Insufficiency; Respiratory Sounds; Sex Chromosome Aberrations; X Chromosome | 1994 |
Dopa responsive dystonia with diurnal fluctuation (Segawa's syndrome).
Topics: Child; Circadian Rhythm; Diagnosis, Differential; Dystonia; Female; Humans; Levodopa | 1994 |
Biochemical and fluorodopa positron emission tomographic findings in an asymptomatic carrier of the gene for dopa-responsive dystonia.
Topics: Adolescent; Adult; Aged; Biopterins; Dystonia; Female; Fluorine Radioisotopes; Heterozygote; Homovanillic Acid; Humans; Levodopa; Male; Neopterin; Pedigree; Tomography, Emission-Computed | 1994 |
Levodopa-induced dyskinesias in Parkinson's disease phenomenology and pathophysiology.
Topics: Activities of Daily Living; Adult; Aged; Chorea; Dose-Response Relationship, Drug; Drug Administration Schedule; Dyskinesia, Drug-Induced; Dystonia; Electromyography; Female; Humans; Levodopa; Male; Middle Aged; Motor Activity; Motor Skills; Neurologic Examination; Parkinson Disease; Parkinson Disease, Secondary; Receptors, Dopamine D1; Video Recording | 1994 |
[Segawa's disease: progressive dystonia responsive to L-dopa. A case report].
Topics: Adult; Benserazide; Diagnosis, Differential; Dystonia; Female; Humans; Levodopa; Neurologic Examination | 1993 |
Lessons from a remarkable family with dopa-responsive dystonia.
Topics: Adult; Aged; Aged, 80 and over; Dystonia; Female; Humans; Levodopa; Male; Middle Aged; Pedigree | 1994 |
Severe evening dyskinesias in advanced Parkinson's disease: clinical description, relation to plasma levodopa, and treatment.
Topics: Aged; Antiparkinson Agents; Bromocriptine; Carbidopa; Chorea; Circadian Rhythm; Delayed-Action Preparations; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Combinations; Drug Therapy, Combination; Dyskinesia, Drug-Induced; Dystonia; Female; Humans; Levodopa; Male; Middle Aged; Neurologic Examination; Parkinson Disease | 1994 |
Positron emission tomographic studies of dopa-responsive dystonia and early-onset idiopathic parkinsonism.
Topics: Adolescent; Adult; Corpus Striatum; Diagnosis, Differential; Dihydroxyphenylalanine; Dystonia; Female; Fluorine Radioisotopes; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Prognosis; Tomography, Emission-Computed | 1993 |
[Methylmalonic acidemia with bilateral MRI high intensities of the globus pallidus].
Topics: Amino Acid Metabolism, Inborn Errors; Child; Dystonia; Female; Globus Pallidus; Humans; Levodopa; Magnetic Resonance Imaging; Methylmalonic Acid | 1993 |
[A form of dopa-responsive dystonia of late onset with diurnal fluctuations].
Topics: Age Factors; Aged; Circadian Rhythm; Dystonia; Female; Humans; Levodopa | 1993 |
Successful treatment of childhood onset symptomatic dystonia with levodopa.
Topics: Adolescent; Adult; Dystonia; Female; Humans; Levodopa; Male | 1993 |
Comparison of striatal 18F-dopa uptake in adult-onset dystonia-parkinsonism, Parkinson's disease, and dopa-responsive dystonia.
Topics: Adult; Age Factors; Caudate Nucleus; Dihydroxyphenylalanine; Dystonia; Female; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Putamen; Tomography, Emission-Computed | 1993 |
Dopa-responsive dystonia of childhood.
Topics: Adolescent; Biopterins; Child; Child, Preschool; Diagnosis, Differential; Dystonia; Electromyography; Female; Gait; Humans; Infant; Levodopa; Male; Muscle Tonus; Polysomnography; Posture; Sex Factors; Sleep Wake Disorders; Synaptic Transmission | 1993 |
End-of-dose dystonia in Parkinson's disease.
Topics: Adult; Carbidopa; Dystonia; Humans; Infusions, Intravenous; Levodopa; Middle Aged; Parkinson Disease; Selegiline; Substance Withdrawal Syndrome | 1993 |
Different cerebral metabolism between parkinsonian rigidity and hyperkinesia (DID, chorea, dystonia). A PET study.
Topics: Basal Ganglia; Blood Glucose; Brain Mapping; Cerebral Cortex; Chorea; Dominance, Cerebral; Dystonia; Energy Metabolism; Humans; Hyperkinesis; Levodopa; Muscle Rigidity; Neural Pathways; Oxygen Consumption; Parkinson Disease; Thalamic Nuclei; Tomography, Emission-Computed | 1993 |
CSF biopterin levels and clinical features of patients with juvenile parkinsonism.
Topics: Adult; Biopterins; Dose-Response Relationship, Drug; Dystonia; Female; Humans; Levodopa; Male; Middle Aged; Neopterin; Neurologic Examination; Parkinson Disease; Parkinson Disease, Secondary; Risk Factors; Thalamic Nuclei | 1993 |
Clinical heterogeneity of dopa-responsive dystonia: PET observations.
Topics: Adult; Aged; Corpus Striatum; Diagnosis, Differential; Dihydroxyphenylalanine; Dystonia; Female; Humans; Levodopa; Male; Middle Aged; Neurologic Examination; Parkinson Disease; Parkinson Disease, Secondary; Receptors, Dopamine; Tomography, Emission-Computed | 1993 |
PET scan study on the dopaminergic system in a Japanese patient with hereditary progressive dystonia (Segawa's disease). Case report.
Topics: Corpus Striatum; Dihydroxyphenylalanine; Dystonia; Female; Humans; Japan; Levodopa; Middle Aged; Neurologic Examination; Parkinson Disease; Parkinson Disease, Secondary; Tomography, Emission-Computed | 1993 |
Clinical features and medical treatment of Parkinson's disease in patient groups selected in accordance with age at onset.
Topics: Adult; Age Factors; Aged; Dose-Response Relationship, Drug; Dystonia; Female; Humans; Levodopa; Long-Term Care; Male; Middle Aged; Movement Disorders; Neurologic Examination; Parkinson Disease; Risk Factors | 1993 |
Effect of L-dopa on oculogyric crises in a case of dopa-responsive dystonia.
Topics: Adult; Dose-Response Relationship, Drug; Dystonia; Female; Humans; Levodopa; Neurologic Examination; Ocular Motility Disorders | 1993 |
Recessively inherited L-DOPA-responsive dystonia caused by a point mutation (Q381K) in the tyrosine hydroxylase gene.
Topics: Animals; Base Sequence; Codon; Dystonia; Escherichia coli; Genes, Recessive; Homozygote; Humans; Levodopa; Molecular Sequence Data; Mutagenesis, Site-Directed; Phenotype; Point Mutation; Polymerase Chain Reaction; Protein Biosynthesis; Rabbits; Recombinant Proteins; Transcription, Genetic; Tyrosine 3-Monooxygenase | 1995 |
Dopa-responsive dystonia of childhood: a case report.
Topics: Child, Preschool; Diagnosis, Differential; Dopamine Agents; Dystonia; Gait; Humans; Levodopa; Male | 1995 |
Levodopa-induced dyskinesias improved by a glutamate antagonist in Parkinsonian monkeys.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Antiparkinson Agents; Behavior, Animal; Chorea; Dyskinesia, Drug-Induced; Dystonia; Excitatory Amino Acid Antagonists; Female; Isoquinolines; Levodopa; Macaca fascicularis; Macaca mulatta; Male; Parkinson Disease, Secondary; Receptors, N-Methyl-D-Aspartate | 1996 |
Dopa-responsive dystonia: clinical and family study in Taiwanese.
Topics: Adult; Carbidopa; Drug Therapy, Combination; Dystonia; Female; Humans; Levodopa; Pedigree | 1996 |
Belly dystonia induced by levodopa and biperiden in a case of suspected multiple-system atrophy.
Topics: Abdominal Muscles; Aged; Antiparkinson Agents; Autonomic Nervous System Diseases; Biperiden; Dose-Response Relationship, Drug; Drug Therapy, Combination; Dystonia; Electromyography; Humans; Levodopa; Male; Neurologic Examination; Olivopontocerebellar Atrophies; Parkinson Disease | 1996 |
Dopa-responsive dystonia in British patients: new mutations of the GTP-cyclohydrolase I gene and evidence for genetic heterogeneity.
Topics: Dopamine Agents; Dystonia; England; Female; Genetic Heterogeneity; GTP Cyclohydrolase; Heterozygote; Humans; Levodopa; Male; Mutation; Sequence Analysis, DNA | 1996 |
Segawa disease.
Topics: Adolescent; Antiparkinson Agents; Dystonia; Female; Humans; Levodopa | 1996 |
[Dystonia preceding dopa-responsive parkinsonism--heterogeneous clinical features].
Topics: Adult; Age of Onset; Aged; Dystonia; Electromyography; Female; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Retrospective Studies; Smoking | 1996 |
[A case of familial juvenile dystonia-parkinsonism: 18F-6-fluorodopa and 18F-fluoro-2-deoxyglucose PET study].
Topics: Adult; Age of Onset; Brain; Deoxyglucose; Dihydroxyphenylalanine; Dystonia; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Glucose; Humans; Levodopa; Parkinson Disease; Tomography, Emission-Computed | 1996 |
Mutant GTP cyclohydrolase I mRNA levels contribute to dopa-responsive dystonia onset.
Topics: Adult; Amino Acid Sequence; Base Sequence; Circadian Rhythm; Dystonia; Exons; Female; GTP Cyclohydrolase; Histidine; Humans; Introns; Japan; Levodopa; Male; Nuclear Family; Point Mutation; Polymerase Chain Reaction; Proline; RNA, Messenger | 1996 |
Dopa-responsive childhood dystonia: a forme fruste with writer's cramp, triggered by exercise.
Topics: Child; Dystonia; Exercise; Female; Foot; Humans; Levodopa; Motor Skills; Writing | 1997 |
Levodopa in pregnancy.
Topics: Abortion, Spontaneous; Adult; Antiparkinson Agents; Carbidopa; Drug Combinations; Dystonia; Female; Humans; Infant, Newborn; Levodopa; Male; Pregnancy; Pregnancy Complications | 1997 |
The perinatal emphasis of Segawa's syndrome.
Topics: Adult; Dystonia; Female; Fetal Membranes, Premature Rupture; Humans; Levodopa; Male; Obstetric Labor Complications; Pregnancy; Pregnancy Complications; Syndrome | 1996 |
6-Pyruvoyl-tetrahydropterin synthase deficiency with generalized dystonia and diurnal fluctuation of symptoms: a clinical and molecular study.
Topics: Adult; Alcohol Oxidoreductases; Antiparkinson Agents; Base Sequence; Benserazide; Circadian Rhythm; Drug Therapy, Combination; Dystonia; Female; Homozygote; Humans; Levodopa; Molecular Sequence Data; Phosphorus-Oxygen Lyases; Point Mutation; Polymerase Chain Reaction; Pterins | 1997 |
[123I]beta-CIT single-photon emission tomography in DOPA-responsive dystonia.
Topics: Adult; Aged; Binding Sites; Cerebellum; Corpus Striatum; Diagnosis, Differential; Dopamine; Dystonia; Female; Humans; Levodopa; Middle Aged; Radioactive Tracers; Tomography, Emission-Computed, Single-Photon | 1997 |
Dopa-responsive, nonprogressive juvenile parkinsonism: report of a case.
Topics: Age of Onset; Antiparkinson Agents; Corpus Striatum; Dopamine; Dystonia; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Tomography, Emission-Computed; Videotape Recording | 1997 |
Differential splicing of the GTP cyclohydrolase I RNA in dopa-responsive dystonia.
Topics: Adult; Alternative Splicing; Base Sequence; DNA Primers; DNA, Complementary; Dystonia; Exons; Female; GTP Cyclohydrolase; Humans; Levodopa; Molecular Sequence Data; Nucleic Acid Conformation; RNA; RNA Precursors; Tissue Distribution | 1997 |
[Hereditary progressive dystonia (dystonia responding to L-dopa) in a Spanish family].
Topics: Adult; Aged; Dopamine Agents; Dystonia; Female; Humans; Levodopa; Male | 1997 |
Mutations in the tyrosine hydroxylase gene cause various forms of L-dopa-responsive dystonia.
Topics: Adult; Child; Dystonia; Humans; Levodopa; Mutation; Tyrosine 3-Monooxygenase | 1998 |
Is levodopa toxic to human substantia nigra?
Topics: Adult; Aged; Aged, 80 and over; Child; Dystonia; Female; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Substantia Nigra; Time Factors; Tomography, Emission-Computed; Tremor | 1997 |
Bilateral posteroventral pallidotomy in advanced Parkinson's disease in three patients.
Topics: Activities of Daily Living; Age of Onset; Antiparkinson Agents; Drug Resistance; Dyskinesia, Drug-Induced; Dystonia; Female; Follow-Up Studies; Globus Pallidus; Humans; Hypokinesia; Levodopa; Male; Middle Aged; Muscle Rigidity; Parkinson Disease; Pilot Projects; Prospective Studies; Severity of Illness Index; Treatment Outcome | 1997 |
A novel mutation of the GTP-cyclohydrolase I gene in a patient with hereditary progressive dystonia/dopa-responsive dystonia.
Topics: Adult; Circadian Rhythm; Dystonia; Electromyography; Female; GTP Cyclohydrolase; Humans; Levodopa; Lysine; Muscle, Skeletal; Point Mutation; Polymerase Chain Reaction; Threonine; Torticollis; Tremor | 1998 |
The choice of anesthesia in Segawa's syndrome.
Topics: Adult; Anesthesia, Epidural; Anesthesia, General; Anesthesia, Obstetrical; Cesarean Section; Dystonia; Female; Humans; Infant, Newborn; Levodopa; Pregnancy; Syndrome | 1998 |
Square-wave action dystonia in Parkinson's disease.
Topics: Antiparkinson Agents; Carbidopa; Dominance, Cerebral; Drug Combinations; Dystonia; Globus Pallidus; Humans; Levodopa; Male; Middle Aged; Neurologic Examination; Parkinson Disease | 1998 |
Dopa-responsive dystonia: some pieces of the puzzle are still missing.
Topics: Dopamine Agents; Dystonia; Humans; Levodopa | 1998 |
Gender-related penetrance and de novo GTP-cyclohydrolase I gene mutations in dopa-responsive dystonia.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Child; DNA Mutational Analysis; Dopamine Agents; Dystonia; Exons; Family Health; Female; Genes, Dominant; GTP Cyclohydrolase; Humans; Introns; Levodopa; Male; Middle Aged; Penetrance; Point Mutation; Sex Factors | 1998 |
Reduced lymphoblast neopterin detects GTP cyclohydrolase dysfunction in dopa-responsive dystonia.
Topics: Adult; Aged; Aged, 80 and over; Alcohol Oxidoreductases; Cell Line; Dopamine Agents; Dystonia; Family Health; Female; GTP Cyclohydrolase; Humans; Interferon-gamma; Interleukin-2; Levodopa; Lipopolysaccharides; Lymphocyte Activation; Lymphocytes; Middle Aged; Neopterin; Pedigree; Sequence Analysis, DNA | 1998 |
Striatal D2 receptors in symptomatic and asymptomatic carriers of dopa-responsive dystonia measured with [11C]-raclopride and positron-emission tomography.
Topics: Adult; Age Factors; Age of Onset; Biopterins; Carbon Radioisotopes; Corpus Striatum; Dopamine Agents; Dopamine Antagonists; Dystonia; Female; Heterozygote; Humans; Levodopa; Male; Middle Aged; Raclopride; Receptors, Dopamine D2; Salicylamides; Sex Factors; Synaptic Membranes; Tomography, Emission-Computed | 1998 |
Tardive dyskinesia in dopa-responsive dystonia: a reappraisal of the dopamine hypothesis of tardive dyskinesia.
Topics: Adult; Anti-Dyskinesia Agents; Dopamine; Dopamine Agents; Dyskinesia, Drug-Induced; Dystonia; Family Health; Female; GTP Cyclohydrolase; Haloperidol; Humans; Levodopa; Male; Point Mutation | 1998 |
High penetrance and pronounced variation in expressivity of GCH1 mutations in five families with dopa-responsive dystonia.
Topics: Adolescent; Adult; Aged; Antiparkinson Agents; Base Sequence; DNA Primers; Dystonia; Family Health; Female; Gene Expression; Genetic Variation; GTP Cyclohydrolase; Humans; Levodopa; Male; Middle Aged; Molecular Sequence Data; Mutation; Pedigree; Penetrance; Polymorphism, Single-Stranded Conformational; Sex Factors | 1998 |
The GTP cyclohydrolase I gene in Russian families with dopa-responsive dystonia.
Topics: Amino Acid Sequence; Dystonia; Gene Expression; GTP Cyclohydrolase; Humans; Levodopa; Molecular Sequence Data; Pedigree; Point Mutation; Russia | 1998 |
Dopamine transporter density measured by [123I]beta-CIT single-photon emission computed tomography is normal in dopa-responsive dystonia.
Topics: Adult; Brain; Carrier Proteins; Child; Diagnosis, Differential; DNA Mutational Analysis; Dopamine; Dopamine Agents; Dopamine Plasma Membrane Transport Proteins; Dystonia; Exons; Family Health; Female; Gene Expression Regulation, Enzymologic; GTP Cyclohydrolase; Humans; Iodine Radioisotopes; Levodopa; Male; Membrane Glycoproteins; Membrane Transport Proteins; Middle Aged; Neopterin; Nerve Tissue Proteins; Parkinson Disease; Pedigree; Tomography, Emission-Computed, Single-Photon | 1998 |
Dopa responsive dystonia with Turner's syndrome: clinical, genetic, and neuropsychological studies in a family with a new mutation in the GTP-cyclohydrolase I gene.
Topics: Adult; Antiparkinson Agents; Brain; Chromosome Aberrations; Chromosome Disorders; Chromosomes, Human, Pair 14; Cognition Disorders; Dystonia; Exons; Female; GTP Cyclohydrolase; Humans; Levodopa; Magnetic Resonance Imaging; Middle Aged; Neuropsychological Tests; Pedigree; Point Mutation; Turner Syndrome | 1998 |
Dystonia with motor delay in compound heterozygotes for GTP-cyclohydrolase I gene mutations.
Topics: Adolescent; Adult; Antioxidants; Biopterins; Child; DNA; Drug Therapy, Combination; Dystonia; Female; Frameshift Mutation; Humans; Levodopa; Male; Middle Aged; Pedigree; Point Mutation | 1998 |
[Long chronic course of hemiparkinson-plus with l-dopa maintained response].
Topics: Aged; Antiparkinson Agents; Chronic Disease; Disease Progression; Dose-Response Relationship, Drug; Dystonia; Functional Laterality; Humans; Levodopa; Male; Parkinson Disease | 1998 |
Early morning dystonia in Parkinson's disease.
Topics: Adult; Aged; Antiparkinson Agents; Drug Administration Schedule; Dystonia; Humans; Levodopa; Middle Aged; Parkinson Disease; Time Factors | 1998 |
A common point mutation in the tyrosine hydroxylase gene in autosomal recessive L-DOPA-responsive dystonia in the Dutch population.
Topics: Chromosomes, Human, Pair 11; Denmark; Dystonia; Genes, Recessive; Humans; Levodopa; Point Mutation; Polymorphism, Single-Stranded Conformational; Tyrosine 3-Monooxygenase | 1998 |
Beneficial effects of combined L-dopa and central anticholinergic in a patient with severe drug-induced parkinsonism and tardive dystonia.
Topics: Antiparkinson Agents; Antipsychotic Agents; Cholinergic Antagonists; Drug Therapy, Combination; Dyskinesia, Drug-Induced; Dystonia; Female; Humans; Levodopa; Middle Aged | 1998 |
Biochemical hallmarks of tyrosine hydroxylase deficiency.
Topics: Adolescent; Age Factors; Biomarkers; Carbidopa; Child; Child, Preschool; Dopamine Agents; Drug Therapy, Combination; Dystonia; Female; Humans; Infant; Levodopa; Male; Reference Values; Specimen Handling; Tyrosine 3-Monooxygenase | 1998 |
Dystonias responding to levodopa and failure in biopterin metabolism.
Topics: Biopterins; Child, Preschool; Dopamine Agents; Dystonia; Family Health; Female; GTP Cyclohydrolase; Humans; Infant; Levodopa; Male; Muscle, Skeletal; Mutation; Phenylketonurias; Phosphorus-Oxygen Lyases | 1998 |
The effect of GTP cyclohydrolase-1 on tyrosine hydroxylase expression: implications in DOPA-responsive dystonia.
Topics: Animals; Antibodies; Cells, Cultured; Dopamine Agents; Dystonia; Fibroblasts; Gene Expression Regulation, Enzymologic; Graft Survival; GTP Cyclohydrolase; In Situ Hybridization; Levodopa; Rats; Rats, Inbred F344; RNA, Messenger; Transgenes; Tyrosine 3-Monooxygenase | 1998 |
Dopa-responsive dystonia: a syndrome of selective nigrostriatal dopamine deficiency.
Topics: Adolescent; Adult; Age of Onset; Biopterins; Child; Cocaine; Corpus Striatum; DNA Mutational Analysis; Dopamine; Dopamine Agents; Dystonia; Female; GTP Cyclohydrolase; Humans; Iodine Radioisotopes; Levodopa; Male; Mutation; Neopterin; Pedigree; Substantia Nigra; Tomography, Emission-Computed, Single-Photon; Tomography, X-Ray Computed | 1998 |
Sudden appearance of invalidating dyskinesia-dystonia and off fluctuations after the introduction of levodopa in two dopaminomimetic drug naive patients with stage IV Parkinson's disease.
Topics: Aged; Antiparkinson Agents; Dyskinesia, Drug-Induced; Dystonia; Humans; Levodopa; Male; Parkinson Disease; Severity of Illness Index | 1998 |
Long-term follow-up of levodopa responsiveness in generalized dystonia.
Topics: Antiparkinson Agents; Dose-Response Relationship, Drug; Dystonia; Follow-Up Studies; Humans; Levodopa; Severity of Illness Index; Time Factors; Tomography, Emission-Computed | 1998 |
A novel de novo point mutation in the GTP cyclohydrolase I gene in a Japanese patient with hereditary progressive and dopa responsive dystonia.
Topics: Alleles; Child; Dystonia; Female; GTP Cyclohydrolase; Humans; Japan; Levodopa; Pedigree; Point Mutation | 1998 |
GTP cyclohydrolase deficiency; intrafamilial variation in clinical phenotype, including levodopa responsiveness.
Topics: Antiparkinson Agents; Child; Chromosomes, Human, Pair 14; Dystonia; GTP Cyclohydrolase; Humans; Levodopa; Male; Pedigree; Phenotype; Point Mutation; Treatment Outcome | 1999 |
[Dopa-responsive dystonia of childhood].
Topics: Child; Diagnosis, Differential; Dopamine Agents; Dystonia; Female; Humans; Levodopa | 1999 |
Follow-up findings in regional cerebral blood flow (r-CBF)-SPECT in a case of idiopathic childhood hemidystonia. Functional neuroimaging and pathophysiological implications.
Topics: Anticonvulsants; Brain; Carbamazepine; Cerebrovascular Circulation; Child; Dystonia; Female; Follow-Up Studies; Functional Laterality; Humans; Levodopa; Magnetic Resonance Imaging; Radiopharmaceuticals; Regional Blood Flow; Technetium Tc 99m Exametazime; Tomography, Emission-Computed, Single-Photon | 1999 |
Dopa responsive dystonia in a girl with vitiligo.
Topics: Adolescent; Anti-Dyskinesia Agents; Carbidopa; Circadian Rhythm; Dopamine Agents; Drug Combinations; Dystonia; Female; Follow-Up Studies; Humans; Levodopa; Vitiligo | 1998 |
Clinical rating of dyskinesias in Parkinson's disease: use and reliability of a new rating scale.
Topics: Antiparkinson Agents; Dystonia; Female; Humans; Hyperkinesis; Levodopa; Male; Middle Aged; Parkinson Disease; Reproducibility of Results; Severity of Illness Index; Time Factors | 1999 |
[Molecular biology examinations of dopa-responsive dystonia].
Topics: Dopamine Agents; Dystonia; GTP Cyclohydrolase; Humans; Levodopa; Mass Screening; Polymerase Chain Reaction | 1999 |
From off-period dystonia to peak-dose chorea. The clinical spectrum of varying subthalamic nucleus activity.
Topics: Adult; Antiparkinson Agents; Chorea; Dyskinesia, Drug-Induced; Dystonia; Female; Follow-Up Studies; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Periodicity; Thalamic Nuclei | 1999 |
A novel mutation in the GTP cyclohydrolase I gene associated with a broad range of clinical presentations in a family with autosomal dominant dopa-responsive dystonia.
Topics: Antiparkinson Agents; Carbidopa; DNA; Dystonia; Exons; Genes, Dominant; GTP Cyclohydrolase; Humans; Jews; Levodopa; Point Mutation; Polymorphism, Genetic; Polymorphism, Single-Stranded Conformational | 1999 |
SSRI-induced reversal of levodopa benefit in two patients with dopa-responsive dystonia.
Topics: Adult; Antiparkinson Agents; Dystonia; Female; Fluoxetine; Humans; Levodopa; Recurrence; Selective Serotonin Reuptake Inhibitors; Stress, Psychological | 1999 |
Severe off-period facial dystonia in Parkinson's disease.
Topics: Antiparkinson Agents; Dystonia; Humans; Levodopa; Male; Masseter Muscle; Middle Aged; Parkinson Disease; Spasm; Tooth Fractures | 2000 |
Two previously unrecognized splicing mutations of GCH1 in Dopa-responsive dystonia: exon skipping and one base insertion.
Topics: Adolescent; Adult; Alternative Splicing; Amino Acid Sequence; Antiparkinson Agents; Base Sequence; Child; Child, Preschool; DNA; DNA Mutational Analysis; Dystonia; Exons; Female; Follow-Up Studies; Frameshift Mutation; GTP Cyclohydrolase; Humans; Levodopa; Mutation; Point Mutation; Polymorphism, Single-Stranded Conformational | 1997 |
Putaminal necrosis presenting with hemidystonia.
Topics: Antiparkinson Agents; Brain Diseases; Child; Dihydroxyphenylalanine; Dose-Response Relationship, Drug; Dystonia; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Levodopa; Magnetic Resonance Imaging; Necrosis; Putamen; Tomography, Emission-Computed; Treatment Outcome | 2000 |
Dopa-responsive dystonia due to a large deletion in the GTP cyclohydrolase I gene.
Topics: Adult; Blotting, Southern; DNA Mutational Analysis; DNA, Complementary; Dopamine Agents; Dystonia; Family Health; Female; Gene Deletion; GTP Cyclohydrolase; Humans; Levodopa; Male; Middle Aged; Pedigree | 2000 |
[Dystonia responsive to L-dopa].
Topics: Child, Preschool; Dystonia; Humans; Levodopa; Treatment Outcome | 1999 |
The predictive validity of the drug-naive bilaterally MPTP-treated monkey as a model of Parkinson's disease: effects of L-DOPA and the D1 agonist SKF 82958.
Topics: Animals; Antiparkinson Agents; Arm; Behavior, Animal; Benzazepines; Dopamine Agents; Dopamine Agonists; Dyskinesia, Drug-Induced; Dystonia; Electroencephalography; Epilepsy; Levodopa; Macaca mulatta; Male; Motor Activity; Movement; MPTP Poisoning; Parkinson Disease, Secondary; Predictive Value of Tests; Receptors, Dopamine D1 | 1999 |
Levodopa-responsive dystonia. GTP cyclohydrolase I or parkin mutations?
Topics: Adolescent; Adult; Antiparkinson Agents; Child; DNA Mutational Analysis; Dystonia; Family Health; Female; Gene Deletion; Genotype; GTP Cyclohydrolase; Humans; Levodopa; Ligases; Male; Middle Aged; Mutation, Missense; Pedigree; Phenotype; Proteins; Reverse Transcriptase Polymerase Chain Reaction; RNA Splicing; Ubiquitin-Protein Ligases | 2000 |
Parkinsonism, dystonia, and hemiatrophy.
Topics: Adolescent; Antiparkinson Agents; Carbidopa; Caudate Nucleus; Child; Child, Preschool; Dominance, Cerebral; Drug Therapy, Combination; Dystonia; Humans; Infant; Infant, Newborn; Levodopa; Magnetic Resonance Imaging; Muscular Atrophy; Neurologic Examination; Parkinson Disease; Putamen; Treatment Outcome | 2000 |
Scoliosis in a dopa-responsive dystonia family with a mutation of the GTP cyclohydrolase I gene.
Topics: Adult; Antiparkinson Agents; Dystonia; Female; GTP Cyclohydrolase; Humans; Levodopa; Mutation, Missense; Pedigree; Scoliosis | 2000 |
Increased blink rate in advanced Parkinson's disease: a form of 'off'-period dystonia?
Topics: Adult; Aged; Antiparkinson Agents; Blinking; Case-Control Studies; Dystonia; Female; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Severity of Illness Index | 2000 |
Dystonia in corticobasal degeneration.
Topics: Adult; Aged; Anti-Dyskinesia Agents; Basal Ganglia; Botulinum Toxins; Cerebral Cortex; Contracture; Dopamine Agonists; Dystonia; Female; Humans; Levodopa; Male; Middle Aged; Muscle, Skeletal; Neurodegenerative Diseases; Pain; Retrospective Studies | 2001 |
New nonsense mutation in the GTP-cyclohydrolase I gene in L-DOPA responsive dystonia-parkinsonism.
Topics: Adult; Aged; Antiparkinson Agents; Codon, Nonsense; DNA Mutational Analysis; Dystonia; Female; Gene Expression; GTP Cyclohydrolase; Humans; Levodopa; Male; Parkinsonian Disorders; Pedigree; Point Mutation | 2001 |
A novel nonsense mutation of the GTP cyclohydrolase I gene in a family with dopa-responsive dystonia.
Topics: Child; Codon, Nonsense; DNA Mutational Analysis; Dystonia; Exons; Female; GTP Cyclohydrolase; Humans; Levodopa; Male; Pedigree; Polymerase Chain Reaction | 2001 |
Response to levodopa treatment in dopa-responsive dystonia.
Topics: Adult; Antiparkinson Agents; Dopamine; Dystonia; Dystonic Disorders; Female; Humans; Levodopa; Male; Middle Aged; Parkinsonian Disorders; Pilot Projects | 2001 |
The long-term response to levodopa in dopa-responsive dystonia.
Topics: Adolescent; Adult; Aged; Dihydroxyphenylalanine; Dopamine Agents; Dystonia; Female; Humans; Levodopa; Male; Middle Aged; Retrospective Studies; Time Factors; Walking | 2001 |
A splice mutation in the GTP cyclohydrolase I gene causes dopa-responsive dystonia by exon skipping.
Topics: Alleles; Amino Acid Sequence; Aromatic Amino Acid Decarboxylase Inhibitors; Base Sequence; Benserazide; Biopterins; Cells, Cultured; Child, Preschool; Dihydroxyphenylalanine; Drug Combinations; Dystonia; Enzyme Inhibitors; Exons; Female; Fibroblasts; GTP Cyclohydrolase; Humans; Introns; Levodopa; Male; Mutation; Neopterin; RNA Splicing; RNA, Messenger | 2001 |
Levodopa prolongs life expectancy and is non-toxic to substantia nigra.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antiparkinson Agents; Cadaver; Child; Disease Progression; Dystonia; Female; Humans; Levodopa; Longevity; Male; Middle Aged; Parkinsonian Disorders; Retrospective Studies; Substantia Nigra; Survival Analysis; Tremor | 2001 |
Dystonia in multiple system atrophy.
Topics: Aged; Brain; Dyskinesia, Drug-Induced; Dystonia; Female; Humans; Levodopa; Male; Middle Aged; Multiple System Atrophy; Neurologic Examination; Parkinson Disease, Secondary | 2002 |
Neuropathology of a case of dopa-responsive dystonia associated with a new genetic locus, DYT14.
Topics: Aged; Antiparkinson Agents; Dystonia; Female; Humans; Levodopa; Male; Pedigree; Substantia Nigra | 2002 |
The treatment of the choreas and athetotic dystonias.
Topics: Adult; Athetosis; Benzodiazepines; Child; Chorea; Dystonia; Haloperidol; Humans; Levodopa; Movement Disorders; Phenelzine; Phenothiazines; Pimozide; Tetrabenazine; Valproic Acid | 1979 |
Early-morning dystonia. A late side effect of long-term levodopa therapy in Parkinson's disease.
Topics: Adult; Dystonia; Female; Humans; Levodopa; Middle Aged; Parkinson Disease | 1979 |
[Levodopa treatment of a case of torsion spasm with athetosis].
Topics: Athetosis; Child; Dystonia; Female; Humans; Levodopa; Spasm | 1979 |
[On a muscular dystony case from manganism. Therapeutic clinic considerations (author's transl)].
Topics: Benserazide; Diazepam; Dystonia; Haloperidol; Humans; Hydrazines; Levodopa; Male; Manganese; Middle Aged | 1979 |
Effects of pharmacological manipulation of dopaminergic and cholinergic neurotransmission in genetically dystonic hamsters.
Topics: Acetylcholine; Animals; Apomorphine; Behavior, Animal; Carbidopa; Cricetinae; Dopamine; Drug Interactions; Dystonia; Haloperidol; Levodopa; Mesocricetus; Motor Activity; Mutation; Pilocarpine; Synaptic Transmission; Trihexyphenidyl | 1992 |
Long-term treatment response and fluorodopa positron emission tomographic scanning of parkinsonism in a family with dopa-responsive dystonia.
Topics: Adult; Aged; Brain; Child; Child, Preschool; Dihydroxyphenylalanine; Dystonia; Family; Female; Fluorine Radioisotopes; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Pedigree; Tomography, Emission-Computed | 1992 |
Hereditary progressive dystonia with diurnal fluctuation (Segawa's syndrome)--an unusual case.
Topics: Body Weight; Child; Chromosomes, Human, Pair 9; Circadian Rhythm; Dihydroxyphenylalanine; Dystonia; Female; Humans; Levodopa; Muscle Tonus; Neurologic Examination | 1992 |
Delayed cyanide induced dystonia.
Topics: Adolescent; Adult; Apomorphine; Atrophy; Brain Damage, Chronic; Cerebral Cortex; Dystonia; Electroencephalography; Follow-Up Studies; Humans; Levodopa; Male; Neurologic Examination; Potassium Cyanide; Putamen; Reaction Time | 1992 |
[Dopa-sensitive muscular dystonia. Segawa's syndrome. A case report].
Topics: Child, Preschool; Diagnosis, Differential; Dystonia; Female; Humans; Levodopa | 1992 |
[Dystonia sensitive to levodopa].
Topics: Adult; Dystonia; Female; Humans; Levodopa; Male; Middle Aged | 1992 |
Progressive dystonia with marked diurnal fluctuation.
Topics: Adult; Child; Circadian Rhythm; Dystonia; Female; Humans; Levodopa | 1992 |
Dystonia induced by combined treatment with L-dopa and MK-801 in parkinsonian monkeys.
Topics: Animals; Dizocilpine Maleate; Drug Combinations; Drug Synergism; Dystonia; Levodopa; Male; Motor Activity; Parkinson Disease, Secondary; Reference Values; Saimiri | 1992 |
Consideration on two cases of dystonia-parkinsonism.
Topics: Carbidopa; Child; Dystonia; Female; Homovanillic Acid; Humans; Hydroxyindoleacetic Acid; Levodopa; Methoxyhydroxyphenylglycol; Parkinson Disease, Secondary | 1991 |
Levodopa-associated hemifacial dystonia.
Topics: Aged; Antiparkinson Agents; Carbidopa; Drug Combinations; Dystonia; Facial Muscles; Female; Humans; Levodopa; Parkinson Disease; Putamen | 1991 |
Dopa-responsive dystonia.
Topics: Child; Dystonia; Genes, Dominant; Humans; Levodopa; Spastic Paraplegia, Hereditary | 1991 |
Clinical and genetic analysis of progressive dystonia with diurnal variation.
Topics: Adolescent; Adult; Carbidopa; Child; Child, Preschool; Circadian Rhythm; Drug Combinations; Dystonia; Female; Humans; Levodopa; Male; Middle Aged; Pedigree | 1991 |
Biochemical and neurophysiological investigations in two forms of Segawa's disease.
Topics: Adolescent; Basal Ganglia Diseases; Benserazide; Diagnosis, Differential; Dystonia; Evoked Potentials; Female; Humans; Levodopa; Male; Syndrome; Tyrosine 3-Monooxygenase | 1990 |
Clinical experience with duodenal infusions of levodopa for the treatment of motor fluctuations in Parkinson's disease.
Topics: Carbidopa; Drug Administration Schedule; Drug Therapy, Combination; Duodenum; Dystonia; Humans; Infusion Pumps; Infusions, Parenteral; Levodopa; Long-Term Care; Motor Skills; Neurologic Examination; Parkinson Disease | 1990 |
Cortico-motor neurone conduction in dopa responsive dystonia.
Topics: Adult; Cerebral Cortex; Dystonia; Female; Humans; Levodopa; Motor Neurons; Muscles; Neurologic Examination; Synaptic Transmission | 1990 |
[Hereditary progressive dystonia with marked diurnal fluctuation--a report of two siblings, one of them showing age-dependent changes of symptoms].
Topics: Adult; Age Factors; Circadian Rhythm; Dopamine; Dystonia; Female; Genes, Dominant; Humans; Levodopa; Middle Aged | 1990 |
Induction of chorea and dystonia in parkinsonian primates.
Topics: Animals; Chorea; Dystonia; Levodopa; Macaca fascicularis; MPTP Poisoning; Parkinson Disease, Secondary | 1990 |
Dopa-responsive dystonia: the spectrum of clinical manifestations in a large North American family.
Topics: Adult; Aged; Child; Child, Preschool; Dystonia; Female; Humans; Levodopa; Male; Middle Aged; North America; Parkinson Disease; Pedigree | 1990 |
[Four cases in two families of hereditary progressive dystonia with circadian rhythm].
Topics: Adolescent; Adult; Child; Circadian Rhythm; Dystonia; Female; Humans; Levodopa; Male | 1990 |
Complex dystonia of Parkinson's disease: clinical features and relation to plasma levodopa profile.
Topics: Aged; Dose-Response Relationship, Drug; Dystonia; Facial Muscles; Humans; Levodopa; Middle Aged; Parkinson Disease | 1990 |
Evidence for the role of spinal cord systems in Parkinson's disease-associated pain.
Topics: Aged; Dystonia; Female; Humans; Levodopa; Pain; Parkinson Disease; Spinal Cord | 1990 |
[Effect of L-dopa in dystonia which was worsened by exercise and improved by resting; a care report].
Topics: Adolescent; Dystonia; Exercise; Female; Humans; Levodopa; Rest | 1990 |
Dystonia with marked diurnal variation associated with biopterin deficiency.
Topics: Adolescent; Adult; Biopterins; Carbidopa; Child; Child, Preschool; Circadian Rhythm; Drug Combinations; Dystonia; Female; Homovanillic Acid; Humans; Hydroxyindoleacetic Acid; Levodopa; Male; Neopterin; Sibling Relations | 1988 |
[A study on catecholamine metabolites in CSF in a patient with progressive dystonia with marked diurnal fluctuation].
Topics: Adolescent; Catecholamines; Circadian Rhythm; Dystonia; Female; Homovanillic Acid; Humans; Hydroxyindoleacetic Acid; Levodopa; Methoxyhydroxyphenylglycol | 1988 |
Continuous levodopa infusions to treat complex dystonia in Parkinson's disease.
Topics: Aged; Duodenum; Dystonia; Female; Humans; Infusions, Parenteral; Levodopa; Male; Middle Aged; Osmolar Concentration; Palliative Care; Parkinson Disease | 1989 |
Dopa responsive dystonia: a treatable condition misdiagnosed as cerebral palsy.
Topics: Adult; Cerebral Palsy; Diagnosis, Differential; Dystonia; Female; Humans; Levodopa | 1989 |
Dopa responsive dystonia.
Topics: Adult; Dystonia; Female; Humans; Levodopa | 1989 |
Tyrosine hydroxylase and levodopa responsive dystonia.
Topics: Chromosome Mapping; Chromosomes, Human, Pair 11; DNA Probes; Dystonia; Genetic Linkage; Humans; Levodopa; Parkinson Disease; Pedigree; Polymorphism, Restriction Fragment Length; Tyrosine 3-Monooxygenase | 1989 |
[Clinical characteristics of painful dystonic foot response in patients with Parkinson's disease].
Topics: Aged; Dystonia; Female; Foot; Humans; Levodopa; Male; Middle Aged; Pain; Parkinson Disease | 1989 |
Kinetic study of catecholamine metabolism in hereditary progressive dystonia.
Topics: Adolescent; Catecholamines; Child; Dystonia; Female; Humans; Levodopa; Tyrosine | 1989 |
Motor abnormalities during sleep in patients with childhood hereditary progressive dystonia, and their unaffected family members.
Topics: Adolescent; Adult; Aged; Antiparkinson Agents; Basal Ganglia; Carbidopa; Child; Child, Preschool; Drug Combinations; Dystonia; Female; Genetic Carrier Screening; Humans; Levodopa; Male; Middle Aged; Motor Activity; Sleep Stages; Sleep Wake Disorders; Sleep, REM | 1989 |
Late-onset post-hemiplegic hemidystonia: CT and angiographic findings.
Topics: Adult; Cerebral Angiography; Cerebrovascular Disorders; Corpus Striatum; Dystonia; Female; Hemiplegia; Humans; Levodopa; Neural Pathways; Thalamus; Time Factors; Tomography, X-Ray Computed | 1989 |
Progressive dystonia with diurnal fluctuation.
Topics: Child; Child, Preschool; Circadian Rhythm; Dystonia; Female; Humans; Levodopa | 1989 |
[Response to haloperidol and analysis of growth curve in hereditary progressive dystonia with marked diurnal fluctuation].
Topics: Body Height; Child; Circadian Rhythm; Dystonia; Female; Haloperidol; Humans; Levodopa | 1989 |
[Two siblings of juvenile Parkinson's disease dystonic type (Yokochi type 3) and hereditary progressive dystonia with marked diurnal fluctuation (Segawa)].
Topics: Child; Circadian Rhythm; Dystonia; Family; Humans; Levodopa; Male; Parkinson Disease | 1989 |
Painful Parkinson's disease.
Topics: Acute Disease; Adult; Aged; Antiparkinson Agents; Benserazide; Carbidopa; Drug Administration Schedule; Drug Combinations; Dyskinesia, Drug-Induced; Dystonia; Female; Humans; Levodopa; Male; Middle Aged; Motor Activity; Pain; Parkinson Disease; Time Factors | 1986 |
Effect of tetrahydrobiopterin and 5-hydroxytryptophan on hereditary progressive dystonia with marked diurnal fluctuation: a suggestion of the serotonergic system involvement.
Topics: 5-Hydroxytryptophan; Adult; Biopterins; Child; Circadian Rhythm; Dystonia; Female; Humans; Levodopa | 1988 |
[Serotonergic disturbance in hereditary progressive dystonia--clinical effects of tetrahydrobiopterin and 5-hydroxytryptophan].
Topics: 5-Hydroxytryptophan; Adult; Biopterins; Child; Dopamine; Dystonia; Female; Humans; Levodopa; Neurons; Serotonin | 1988 |
Brain dopaminergic system studied in patients with dystonia using positron emission tomography.
Topics: Adult; Brain; Dopamine; Dystonia; Female; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Spiperone; Tomography, Emission-Computed; Torticollis | 1988 |
Positron tomography in dystonia.
Topics: Brain; Circadian Rhythm; Deoxyglucose; Dystonia; Dystonia Musculorum Deformans; Fluorodeoxyglucose F18; Humans; Levodopa; Putamen; Tissue Distribution; Tomography, Emission-Computed | 1988 |
Dystonia in Parkinson's disease: clinical and pharmacological features.
Topics: Adult; Aged; Circadian Rhythm; Dose-Response Relationship, Drug; Dystonia; Humans; Injections, Intravenous; Levodopa; Middle Aged; Parkinson Disease; Substance Withdrawal Syndrome | 1988 |
Treatable dystonia presenting as spastic cerebral palsy.
Topics: Adolescent; Adult; Carbidopa; Cerebral Palsy; Child; Child, Preschool; Diagnosis, Differential; Dystonia; Humans; Levodopa; Muscle Spasticity | 1988 |
Parkinsonism following dystonia in three patients.
Topics: Adult; Dystonia; Handwriting; Humans; Levodopa; Male; Meige Syndrome; Middle Aged; Muscle Cramp; Parkinson Disease; Time Factors | 1986 |
[Bromocriptine and L-dopa therapy: comparison in a case of hereditary progressive dystonia with marked diurnal fluctuations].
Topics: Adolescent; Bromocriptine; Dystonia; Female; Humans; Levodopa | 1987 |
Forms of dystonia in patients with Parkinson's disease.
Topics: Adult; Aged; Dystonia; Female; Humans; Levodopa; Male; Middle Aged; Parkinson Disease | 1987 |
Fluctuating dystonia responsive to levodopa.
Topics: Child; Child, Preschool; Circadian Rhythm; Diagnosis, Differential; Dystonia; Dystonia Musculorum Deformans; Female; Humans; Levodopa | 1987 |
Dystonia in untreated parkinsonism.
Topics: Adult; Aged; Dystonia; Female; Humans; Levodopa; Male; Middle Aged; Parkinson Disease | 1986 |
Dystonia-Parkinson syndrome: differential effects of levodopa and dopamine agonists.
Topics: Adult; Bromocriptine; Carbidopa; Dystonia; Ergolines; Humans; Levodopa; Meige Syndrome; Middle Aged; Parkinson Disease; Pergolide; Torticollis | 1986 |
DOPA-sensitive progressive dystonia of childhood with fluctuations of symptoms--Segawa's syndrome and possible variants. Results of a collaborative study of the European Federation of Child Neurology Societies (EFCNS).
Topics: Child; Child, Preschool; Circadian Rhythm; Dystonia; Female; Humans; Infant; Levodopa; Male; Syndrome | 1986 |
Hereditary dystonia-parkinsonism syndrome of juvenile onset.
Topics: Adult; Dystonia; Female; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Pedigree | 1986 |
[Hereditary progressive dystonia--an observation of the catecholamine metabolism during L-DOPA therapy in a 9-year-old girl].
Topics: Catecholamines; Child; Dystonia; Female; Humans; Levodopa; Syndrome | 1986 |
Open label evaluation of cannabidiol in dystonic movement disorders.
Topics: Adult; Aged; Cannabidiol; Cannabinoids; Dystonia; Dystonia Musculorum Deformans; Female; Humans; Levodopa; Male; Meige Syndrome; Middle Aged; Muscle Spasticity; Torticollis | 1986 |
Hereditary progressive dystonia with marked diurnal fluctuation: clinicopathophysiological identification in reference to juvenile Parkinson's disease.
Topics: Adolescent; Adult; Aged; Child; Circadian Rhythm; Dystonia; Female; Humans; Levodopa; Male; Parkinson Disease | 1987 |
Foot dystonia in Parkinson's disease: clinical phenomenology and neuropharmacology.
Topics: Adult; Aged; Dystonia; Foot Deformities, Acquired; Humans; Levodopa; Parkinson Disease | 1987 |
Chronic agonist therapy for Parkinson's disease: a 5-year study of bromocriptine and pergolide.
Topics: Aged; Antiparkinson Agents; Bromocriptine; Drug Therapy, Combination; Dyskinesia, Drug-Induced; Dystonia; Ergolines; Female; Hallucinations; Humans; Levodopa; Male; Middle Aged; Nausea; Outcome and Process Assessment, Health Care; Parkinson Disease; Pergolide; Time Factors | 1985 |
[Secondary effects of prolonged levodopa therapy in Parkinson's disease].
Topics: Age Factors; Aged; Amantadine; Antidepressive Agents, Tricyclic; Aromatic Amino Acid Decarboxylase Inhibitors; Bromocriptine; Drug Therapy, Combination; Dystonia; Female; Humans; Levodopa; Male; Mental Disorders; Middle Aged; Parkinson Disease | 1985 |
Hemidystonia: a report of 22 patients and a review of the literature.
Topics: Adolescent; Adult; Aged; Basal Ganglia Diseases; Brain Damage, Chronic; Brain Diseases; Brain Injuries; Carbidopa; Child; Child, Preschool; Dominance, Cerebral; Dystonia; Dystonia Musculorum Deformans; Female; Follow-Up Studies; Humans; Levodopa; Male; Middle Aged; Tomography, X-Ray Computed; Trihexyphenidyl | 1985 |
Progressive dystonia with marked diurnal fluctuation. Report of a case.
Topics: Carbidopa; Child; Circadian Rhythm; Conversion Disorder; Diagnosis, Differential; Drug Therapy, Combination; Dystonia; Female; Humans; Levodopa; Muscle Spasticity; Paraplegia | 1985 |
[Experience with L-DOPA treatment of children with dystonia musculorum deformans and dystonic hyperkineses in infantile cerebral palsy].
Topics: Adolescent; Cerebral Palsy; Child; Child, Preschool; Dystonia; Dystonia Musculorum Deformans; Female; Humans; Hyperkinesis; Levodopa; Male | 1985 |
Idiopathic fluctuating dystonia: a case of foot dystonia and writer's cramp responsive to L-dopa.
Topics: Adult; Dystonia; Female; Foot Deformities, Acquired; Handwriting; Humans; Levodopa; Muscle Cramp | 1985 |